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Chapter 1 
General introduction 
The gonadal functions of male and female individuals are 
mainly regulated by two gonadotrophic hormones, follicle-
stimulating hormone (FSH) and luteinizing hormone (LH) , 
both secreted by the pituitary. In spontaneously ovulating 
mammals (e.g. rat and man) periodic discharges of these 
hormones, resulting in ovulation, are characteristic of the 
female, whereas similar periodic discharges have never been 
observed in the male. Every four or five days female rats 
show a peak in serum LH on the afternoon of the day preced-
ing ovulation (the day of prooestrus), which coincides with 
an increase in serum FSH. The high FSH level is maintained 
till the afternoon of oestrus (Gay et al, 1970; Daane and 
Parlow, 1971). The serum LH peak normally results in ovula-
tion of a number of follicles, which are transformed to 
corpora lutea. In rats these processes recur every four or 
five days. 
It has been known for more than thirty years that andro-
gens administered neonatally to female rats can prevent 
ovulation and corpus luteum formation in the adult animal 
(Bradbury, 1941). These findings are of particular interest 
in conjuction to those of Pfeiffer (1936). He observed that 
ovaries transplanted into adult male rats, castrated at 
birth, showed follicular growth and corpus luteum formation 
similar to those in female rats. On the other hand, implanta-
tion of testes into newborn female rats resulted in the 
absence of ovulations in the ovaries in situ. Furthermore, 
ovaries transplanted into male rats, castrated in adulthood, 
do not display ovulation or formation of corpora lutea 
(Goodman, 1934). On the basis of these observations it was 
concluded that in the rat the type of gonadotrophin regula-
tion in adulthood depends on the presence or absence of 
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testicular hormones in neonatal life (Pfeiffer, 1936). 
Neonatal absence of androgenic hormones in females as well 
as in males permits the development of cyclic activity of 
implanted ovaries. The presence of androgenic hormones 
neonatally, following injection (in the female) or by testi-
cular secretion (in the male) results in non-cyclic activity 
of i~planted ovaries. Since it has been convincingly proven 
that gonadotrophin release is controlled by the brain 
{Harris and campbell, 1966) the sex difference in gonado-
trophin release implies a sex difference in the function-
ing of brain centres controlling gonadotrophin release. It 
is generally assumed that in the presence of androgenic 
hormones during a certain period of neural development -
in the rat perinatally - the undifferentiated brain mechan-
ism controlling the gonadotrophin release is organised so 
as to prevent cyclic gonadotrophin release (Gorski, 1966; 
Harris, 1970). Since androgen administration in neonatal 
female rats results in the development of a patte.rn of 
gonadotrophin secretion sirrilar to that of the male, the 
sterilizing effect of early-androgen treatment has often 
been called "masculinizationn. However, this term tends to 
oversimplify the regulation of gonadal function in the male 
and may erroneously suggest that all sex differences between 
the male and female hypothalarro-hypophysial-gonadal axis 
depend on the neonatal presence of androgens. Therefore we 
prefer the term "androgen-sterilization 11 or "androgeniza-
tion" to describe the effect of neonatal {early) androgen 
treatment. 
This thesis will deal with the influence of neonatal 
androgen injections on the hypothalamo-hypophysial-ovarian 
system in the female rat. Sexual differentiation of the 
regulation of the gonads was the subject of an earlier 
thesis from this laboratory (van der Schoot, 1973) .Further-
more, several excellent reviews on sexual differentiation 
of gonadotrophin regulation are available {Barraclough, 
1966a, 1968; Neumann~ al, 1970; Harris, 1970; Gorski, 1971). 
Androgen-sterilization has been obtained in several mamm-
12 
alian species viz mice (Barraclough and Leathern, 1954; 
Lamond, 1969), hamsters (Alleva et al, 1969; Swanson, 1966) 
and guinea-pigs (Brown-Grant and Sherwood, 1971). It is 
conceivable that androgen-sterilization also occurs in 
primates, including man. At the adrenoqenital syndrome hiqh 
levels of androgenic hormones are present in female fetuses. 
(see Thomas, 1968). Until the present, studies on the effect 
of prenatal androgen in primates have failed to demonstrate 
an effect on fertility (Treloar et al, 1972; Goy and Resko, 
1972). However, behavioral chan~es have been reported in 
such cases (Money and Ehrhardt, 1972; Goy and Resko, 1972) 
Regulation of aonadotrophin release. 
Release of the two gonadotrophic hormones, LH and FSH, 
from the pituitary is controlled by the releasing hormone{s) 
LH-RH (and FSH-RH) (McCann, 1970; Schally et al, 1973). It 
is thought that the releasing hormone is produced in neurons 
endin~ on capillary loops in the median eminence (Barry et al, 
1973). The hormone reaches the pituitary via the portal 
vessels. (Harris, 1955). The releasing hormone producing 
elements are probably, located 1o1i thin the medio-basal part 
of the hypothalamus. Releasing hormone activity has been ob-
served from the optic chiasm to the pituitary stalk (Watanabe 
and McCann, 1968; Criahton et al, 1970). The media-basal part 
of the hypothalamus, by itself, does not produce a stimulus 
releasing sufficient LH-RH for an ovulatory surqe of LH. 
Female rats with lesions in the anterior hypothalamus 
(Hillarp, 1949; Greer, 1953) or knife cuts between the 
anterior hypothalamus and the medial hypothalamus (Hal&sz 
and Gorski, 1967) showed the condition of constant oestrus, 
which is characterized by follicular qrowth without ovula-
tion. Such animals are capable of producina FSH and LH, 
although they do not produce an ovulatory surge of LH. From 
the experiments of Halasz and Gorski (1967) its is concluded 
that the area rostral to the knife cuts is indispensable 
for the induction of the ovulatory LH surge. There is 
fairly good evidence that the anterior hypothalamic-
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preoptic area (AH-POA) plays a wajor role in the regulation 
of the cyclic LH release. Knife cuts frontal to the AH-POAr 
leaving the neural connections of the AH-POA with the medial 
hypothalamus intact, may be followed by spontaneous ovula-
tions (KOves and Halasz, 1978; Kaasjager et al, 1971). This 
suggests that the neural mechanism required for triggering 
of the ovulatory LH surge lies within the preoptic area. 
Also, it has been reported that limbic structures (the 
amygdala and the hippocampus) are involved in the regula-
tion of gonadotrophin release (for review see Zolovick, 1972; 
Wildschut, 1972). The relative importance of these extra-
hypothalamic influences for cyclic LH release is still 
unclear. 
Current theories of the regulation of gonadotrophin release 
involve a dual control mechanism. (1) The medial hypothalamus 
regulates the tonic releaser the gonadotrophin concentration 
in the blood being regulated by the inhibitory feedback 
action of steroids on this area (Taleisnik et al, 1970). 
Also an influence of steroids on the sensitivity of the 
pituitary to releasing hormones is involved in the regula-
tion of the tonic gonadotrophin release (Schally et al, 1973) 
(2) The AH-POA regulates the cyclic gonadotrophin release. 
Under adequate hormonal conditions, in which the stimulatory 
influence of a high oestrogen level plays a role (Brown-
Grant, 1971), the AH-POA activates the RH-producing neurons 
in the media-basal hypothalamus, and this results in an 
ovulatory discharge of LH from the pituitary. 
Regulation of gonadotrophin release in androgen-sterilized 
~-
Although ovulatory LH release is absent in androqen-
sterilized rats, the presence of growing follicles in the 
ovaries and the signs of oestrogen secretion (near normal 
uterine weight and permanent vaginal cornification) indicate 
that some gonadotrophin release is maintained. Direct 
measurements of serum gonadotrophins with radioimmunoassay 
(RIA) in rats made anovulatory by 50 ~g TP show serum LH 
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concentrations similar to those at dioestrus and oestrus in 
cyclic rats (Kawakami and Terasawa, 1972; Kawakami et al, 
1973; Mallampati and Johnson, 1973). In rats made anovul-
atory by 1250 ~g TP, Barraclough (1968) reported extremely 
high concentrations of seruiT'. LH as measured by bioassay, 
even higher than those observed in ovariectomized, untreated 
rats. However, data obtained by the more reliable RIA 
revealed serum LH concentrations in high dose TP-treated 
rats slightly higher than those at oestrus (Labsethwar, 1970, 
3 x 100 ~g TP; Uilenbroek, 1972, 1250 ~g TP; Velasco and 
Rothchild, 1973, 1250 ~g TP}. Data on serum FSH concentrations 
in adult androgen-sterilized rats are limited. It has been 
assumed that the secretion of FSH is tonic, since 4- or 5-
day cyclic changes in serum FSH have never been observed. 
FSH values not different from those at dioestrus in cyclic 
female rats were reported by Johnson (1972) (RIA and bio-
assay) and by Kawakami et al (1973) (RIA). 
An inhibitory feedback action of steroids on gonadotrophin 
secretion which is normally present in intact rats is also 
operative in androgen-sterilized rats as indicated by the 
following findings. After ovariectomy serum gonadotrophins 
increase as was demonstrated in parabiosis experiments 
(Johnson and Witschi, 1"963; Kurcz and Gerhardt, 1968; 
Moguilevsky et al, 1967). However, the increase in ovarian 
weight or accessory genital organs of the parabiotic partner 
of androgenized females was smaller than in the parabiotic 
partner of control females or even absent, if the animals 
were androgenized both with a high dose of TP and at an 
early age (500 "g TP at day 1) (Kurcz et al, 1969; Kurcz 
and Gerhardt, 1968) . It has been suggested that in these 
cases the tonic gonadotrophin control was also affected. 
Direct measurements by bioassay or RIA of serum LH concen-
trations after ovariectomy in rats treated with 100 or 1250 
~g TP on day 5 revealed either no differences (Barraclough, 
1968; Schiavi, 1969; Taleisnik et al, 1969) or lower 
concentrations (Neill, 1972; Uilenbroek, 1972) as compared 
to ovariectomized control rats. Administration of oestrogen 
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to ovariectomized TP-treated rats can suppress or prevent 
the postcastration rise of serum LH (Barraclough, 1968; 
Uilenbroek, 19 7 2 I . 
Data indicative of the regulation of FSH secretion have 
been obtained with experiments in which compensatory ovarian 
hypertrophy was observed after unilateral ovariectomy in 
androgen-sterilized rats (Gorski and Barraclough, 1962; 
a Swanson and van der Werff ten Bosch, 1964 ; Dunlapp et al, 
1972) . This hypertrophy could be prevented by oestrogen 
administration (Petrusz and Nagy, 1967). Direct measurement 
of serum FSH by bioassay in spayed androgenized rats re-
vealed no difference with those in spayed untreated rats 
{Schiavi, 1969). 
The absence of cyclic gonadotrophin release and the 
presence of a tonic gonadotrophin release in TP-treated 
rats suggests an effect of neonatal TP at the AH-POA level. 
This might cause a different reaction to stimulation of the 
AH-POA in TP-treated rats as compared to normal rats. 
However, results obtained with stimulation of the AH-POA to 
induce ovulation are contradictory. Electrical stimulation 
of the AH-POA failed to induce ovulation in androgenized 
female rats (Barraclough and Gorski, 1961; Gorski and 
Barraclough, 1963), although this type of stimulation 
resulted in ovulation in nembutal blocked prooestrous rats 
{Critchlow, 1958; Everett, 1961). From these experiwents it 
was concluded that following neonatal androgen treatment 
the neurons of the AH-POA had become refractory to electri-
a 
cal stimulation (Barraclough, 1966 } . In contrast, results 
obtained with electrochemical stimulation of the AH-POA did 
not show a difference between normal and androgenized rats 
(Terasawa ~ al, 1969; Everett et al, 1970; Kawakami and 
Terasawa, 1972), which suggested that neonatal TP-treatment 
had no effect on the AH-POA. Arai (197lb) suggested that 
the limbic structures are affected by neonatal TP-treatment, 
because in contrast to normal rats ovulation could not be 
induced by electrochemical stimulation of the medial 
amygdaloid nucleus in androgenized rats. 
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Androgenization. 
In early experiments on the influence of neonatal androgen 
treatment on ovulation in adult female rats high doses of 
testosterone propionate (TP) were administered for several 
weeks (Shay et al, 1939; Bradbury, 1940, 1941; Wilson~ al, 
1941). In later experiments a single injection of TP given 
before day 10 of life also resulted in the absence of 
ovulations in all the injected animals (Barraclough and 
Leathern, 1954 and Barraclough, 1955 in mice; Barraclough, 
1961 in rats) . The period during which administration of 
androgen resulted in absence of ovulations has been called 
"the critical period". In the rat this period extends from 
a few days before birth (Swanson and van der Werff ten Bosch, 
1965) till about the lOth day of life. It appeared that all 
the animals injected subcutaneously with a dose of 100 ~g 
TP or more were anovulatory at 10-14 weeks of age (see 
review Neumann et al, 1970). With lower doses only a low 
percentage of the animals was anovulatory at 10-14 weeks 
of age (Gorski and Barraclough, 1963). However, by studying 
the effect of TP at two different ages Swanson and van der 
Werff ten Bosch (1964a) observed that with 5 or 10 ~g TP, 
given on day 5, a number of animals which were ovulatory 
at the age of 10 weeks were anovulatory at the age of 21 
weeks. These findings show that the early-androgen treatment 
does not exert an all- or none-effect, but show that the 
syndrome can develop at later ages. These findings have been 
confirmed by Kikuyarna and Kawashima (1966), Gorski (1968) 
and Arai (197la) and has been called "the delayed anovula-
tion syndrome" (Gorski, 1968) or "the incomplete or delayed 
early-androgen syndrome" (van der Werff ten Bosch ~ al, 
1971 I . 
Scope of this thesis. 
Up until nowr most of the investigations concerning neo-
natal androqenization have been restricted to the later 1 
adult function of the hypothalarno-hypophysial-ovarian axis. 
The aim of the present study was to clarify the develop~ent 
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of the early-androgen syndrome from the day of androgen 
injection onwards. Two types of TP-treated rats have been 
studied: rats treated with a single high dose of TP, which 
exhibited the anovulation syndrome regardless of when they 
were studied, and rats treated with a single low dose of TP, 
which exhibited the anovulation syndrome only after a 
variable period of ovarian cyclicity. These two types of 
androgenized rats have been compared during the prepuberal 
period and also in adulthood when the low dose TP-treated 
rats had finally reached the anovulatory state. 
By establishing the earliest disturbances of sexual matura-
tion following neonatal TP as well as the differences between 
high and low dose TP-treated rats, it was hoped to elucidate 
the development of the early-androgen syndrome. 
Chapter 2 provides the materials and methods section in 
which particularly the radioimmunoassay methods for gona-
dotrophins are described. 
In chapter 3 the effects of a single high and of a single 
low dose of TP given on day 5 on ovarian cyclicity in adult-
hood are described. 
The effects of neonatal TP on ovarian and uterine weights, 
serum gonadotrophins and follicular development during the 
prepuberal period are reported in chapter 4. 
In chapter 5 studies on the influence of neonatal TP on the 
capacity of the brain to induce ovulatory surges of LH are 
described. 
Studies on the effect of neonatal TP-treatment on induction 
of ovulation by electrochemical stimulation of the brain are 
reported in chapter 6. 
Chapter 7 provides a general discussion. 
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Chapter 2 
Materials and methods 
2-1 Animals and treatments. 
Animals. 
All animals used in these experiments were albino rats of 
the Wistar strain. Two substrains were used; an inbred 
substrain from the Department of Endocrinology and Diseases 
of Metabolism at Leiden University (here called "Endo" sub-
strain) and an inbred substrain from the Netherlands Cancer 
Institute at Amsterdam (called R-Amsterdam substrain). 
Animals of both substrains were born in the laboratory and 
housed under conditions of constant temperature and humidity. 
Food, consisting of standard dry pellets (Hope Farms), and 
water were always available. The lighting schedule for both 
substrains was 14 hrs light and 10 hrs darkness. In the 
animal rooms of the "Endo" substrain lights were on from 
08.00 hrs to 22.00 hrs, while in the rooms of the R-Amsterdam 
substrain lights were on from 05.00 hrs to 19.00 hrs. 
Employing the convention of Everett and Sawyer (1950), all 
subsequent references to time in the experiments refer to 
11 colony times". Midday colony time is the midpoint of the 
light period. This was 15.00 hrs standard time for the "Endo" 
substrain and 12.00 hrs standard time for the R-Amsterdam 
substrain. The substrain used will be specified for every 
experiment. 
On day 5 (day of birth is denoted as day 1) all females 
born on the same day were randomly distributed among lactating 
mothers. The group sizes with one mother were kept at eight, 
females being preferred. 
Hormone treatments. 
On day 5 all the females of a group received a single 
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injection of either 5 or 1250 ~g testosterone propionate 
(TP, Neohombreo1, Organon) in 0.05 ml sesame oil or 0.05 ml 
sesame oil alone. The injection was given subcutaneously 
in the neck area. Within a group all animals underwent 
identical treatments. 
Other hormones used in the experiments are: pregnant mare 
serum gonadotrophin (PMSG, Gestyl, Organon), human chorionic 
gonadotrophin (HCC, Pregnyl, Organon), synthetic luteinizing 
hormone releasing hormone (LH-RH, Beckman), and progesterone 
(Organon}. PMSG, HCG and LH-RH were diluted in a 0.9% NaCl 
solution and administered subcutaneously (s.c.) or intrave-
nously (i.v.) in the vena jugularis in a volume of 0.1 ml. 
Progesterone was diluted in sesame oil and given s.c. in a 
volume of 0.1 ml. 
Operations. 
Operations were performed under ether anaesthesia. Hypo-
physectomy was carried out by the parapharyngeal approach; 
completeness was checked at autopsy by examination of the 
sella turcica under the dissecting microscope. 
Blood for determination of gonadotrophic hormones was 
collected by puncture of the ophthalmic venous plexus with 
a broken glass capillary under light ether anaesthesia. Blood 
was allowed to clot in a refrigerator overnight prior to 
centrifugation. Serum was stored at -20°c. 
Autopsy. 
The animals were killed with chloroform. The ovaries and 
uteri were dissected free from adjacent fat and from the 
fallopian tube under a dissecting microscope. 11 Fluid" was 
removed from the uteri by pressing between filter paper. 
The organs were weighed on a Mettler-balance to the nearest 
0.1 mg. Ovaries and uteri from animals younger than 15 days 
and pituitary glands (after removal of the posterior lobe} 
were weighed to the nearest 0.01 rng on a torsion-balance. 
For detection of ovulation the fallopian tubes were dis-
sected and opened with the aid of fine forceps. The ova 
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were counted under a microscope. 
Histology. 
ovaries and brains were fixed in a 5% formalin solution, 
and sectioned at 10~; every tenth section was mounted. For 
counting follicles 5v sections were cut and serial sections 
were mounted. Sections of ovaries were stained with haema-
toxylin and eosin. Brain sections were stained with luxol-
fast-blue (Romeis, 1968). Vaginal smears were stained with 
Giemsa's solution. 
Statistical methods. 
To test the probability of a difference between two 
samples with a normal distribution the data were subjected 
to Student's t-test. When the distribution of data was 
skewed, the probability of a difference was tested using a 
Mann-Whitney U test. (Siegel, 1956). 
Nominal variables are presented in percentages, and to 
test the probability of a difference, the data were sub-
jected to either the Fischer-test (N<10) or a x2-test (N>lO) 
(Siegel, 1956). 
A probability <0.05 (2-tailed) was accepted as the level 
of statistical significance. 
2-2 Radioimmunoassay of gonadotrophins. 
2-2-1 Introduction. 
Until recently quantative estimation of luteinizing 
hormone (LH) and follicle stimulating hormone (FSH) were 
mainly performed with biological assays employing the 
ovarian ascorbic acid depletion test (OAAD, Parlow, 1961) 
for LH estimation and the HCG augmentation test (Steelman 
and Pohley, 1953) for FSH estimation. These bioassays are 
reliable for measuring gonadotrophins in pituitary extracts 
but are not sufficiently sensitive to permit reliable 
measurements in sera from individual rats. The development 
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of the radioimmunoassay (RIA) technique by Yalow and Berson 
(1969) as well as the method of labeling polypeptide hor-
mones with radioactive iodine by Greenwood et al (1963) have 
permitted measurement of 
of sensitivity. This RIA 
peptide hormones with a high degree 
technigue 
measurement of rat LH by Monroe et 
has been applied to the 
al (1968). These authors 
used an antiserum against rat LH and purified rat LH for 
iodination. This homologous assay system has been designated 
as the "RR rat LH RIA", according to the convention of 
Niswender et al (l968b). The first capital letter refers to the 
species from which LH has been obtained for immunization while 
the second capital refers to the species from which the 
purified LH for radioiodination has been obtained. The 
sensitivity of this assay system is at least 200 times higher 
than that of the OAAD-test. However, this sensitivity is not 
sufficient to measure serum LH concentrations during oestrus 
and dioestrus of cyclic female rats. A more sensitive RIA for 
rat LH has been developed by Niswender et al (l968a) based on 
the crossreaction of rat LH with anti-ovine LH (00 rat LH RIA). 
This heterologous rat LH RIA has a sensitivity 20 times as 
high as that of the RR rat LH RIA and is at present the most 
sensitive RIA for rat LH. 
An RIA method for rat FSH has been described by Daane and 
Parlow (1971). The sensitivity of this RR rat FSH RIA system 
permits reliable measurements of serum FSH concentrations 
during late prooestrus and early oestrus, but fails to give 
reliable data during 
1971). A rat FSH RIA 
the rest of the cycle {Daane and Parlow, 
with 
(OR rat FSH RIA) has been 
an antiserum against ovine FSH 
developed (Uilenbroek and Dullaart 
unpublished results) but was not available at the time of 
the. experiments to be reported here. 
2-2-2 Assay systems and standards. 
Two RIA systems were used for measuring rat LH in the 
experiments described in this thesis. They are: 
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1.RR rat LH RIA 
~he antiserum (NIAMD-anti-rat-LH S-2) and the purified 
rat LH (NIAMD-rat-LH I-1) were obtained from the National 
Institute of Arthritis and Metabolic Diseases (NIAMD). 
Daane and Parlow (1971) stated that this system is 
identical to that described by Monroe et al (1968). 
2 .OR rat LH RIA 
The antiserum (anti-ovine-LH 610 V) was obtained by 
immunization of rabbits with NIH-LH-S-17. NIAMD-rat-LH I-1 
was used for iodination. 
Reliability data of these systems are given in 2-2-4. 
For measuring rat FSH the RR rat FSH RIA was used (for 
details see 2-2-5). The antiserum (NIAMD-anti-rat-FSH S-1) 
and the purified rat FSH (NIAMD-rat-FSH I-1} were obtained 
from the NIAMD. 
LH and FSH concentrations are expressed in the widely 
accepted NIAMD rat reference preparations: LH in ng NIAMD-
rat-LH RP-1 (bioassay potency 0.03 NIH-LH-S-1), FSH in ng 
NIAMD-rat-FSH RP-1 (bioassay potency 2.1 NIH-FSH-S-1). 
These preparations were obtained from the NIAMD. 
2-2-3 Procedure. 
Radioiodination. 
The purified hormones were iodinated according to the 
method of Greenwood et al (1963) with some minor modifica-
tions. Prior to the radioiodination procedure a Biogel P 60 
column (Bio Rad Labs, Richmond Cal.) was prepared. The 
column (length about 15 em, diameter 1 ern} was equilibrated 
with 0.01 M phosphate buffered saline (PBS) solution (PH 
7.6). Prior to use 1 ml normal rabbit serum (NRS) or 0.01 M 
PBS containing 2% bovine serum albumin (BSA, Pentex fraction 
V) was passed through the column to reduce nonspecific bind-
ing of protein. Of the purified hormone 2.5 ~g dissolved 
in 25 ~1 distilled water v.ras mixed with 10 ~1 0.5 M sodium 
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phosphate buffer (PH 7.6), 25 ~g chlorarnine-T dissolved 
in 10 )..11 0.01 M PBS and 1 millicurie (mCi) Na 125 r (Radio-
chemical Centre Amersharn or Philips-Duphar). The reaction 
mixture was agitated on a Vortex mixer for exactly 60 sec. 
The reaction was stopped by addition of 62.5 llg sodium 
rnetabisulphite in 100 lll 0.01 M PBS. Carrier-solution (200 
)..11) containing 10 mg Nai/ml PBS was added and the content 
of the vial was transferred to the Biogel column with a 
pipette coated with 0.01 M PBS-2% BSA. The vial was rinsed 
with 300 )..11 carrier-solution, which was then also trans-
ferred to the column. The column was eluted with 0.01 M PBS. 
Ten drops of the column eluate were collected in tubes 
containing 100 )..11 0.01 M PBS-2% BSA. The elution pattern 
shows two peaks of radioactivity: the first one (elution 
volume: 12 ml) of iodinated hormone, the second one (elu-
tion volume: 14 ml) of free 125 r. An aliquot of the protein 
peak with the highest amount of radioactivity was diluted 
with 0.01 M PBS-0.1% BSA to an activity of 10.000-15.000 
cpm/100 )..11 and stored at -20°c. The specific activity of the 
labelled hormone is in the order of 50 to 200 )..ICi/llg; these 
are rough estimates since the amount of 125 r used and the 
amount of protein lost during the iodination procedure are 
not exactly known. 
Radioimmunoassay. 
Various amounts of reference preparation or aliquots of 
unknown samples were diluted to 500 )..11 with PBS-1% BSA. 
Two hundred )..11 antiserum, diluted to an appropriate con-
centration in 0.05 M EDTA-PBS containing 0.25% NRS, was 
added to each tube. After preincubation of this mixture 
for 24 hrs at 4°C, 100 lll iodinated hormone solution 
{10.000-15.000 cprn) was added. After an additional incuba-
tion for 72 hrs at 4°C the antibody bound iodinated hormone 
was separated from the free iodinated hormone by the double 
antibody technique: 200 )..11 of an appropriate dilution of 
anti-rabbit gamma globulin serum (donkey anti-Rgg, Wellcorne) 
in PBS-1% BSA was added to precipitate the first antibody 
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together with the gamma g.lobulin of the NRS. The tubes were 
incubated for another 48 hrs and the total radioactivity of 
the incubation mixture was counted in a Packard automatic 
gamma spectrometer. The tubes were then centrifuged at 3000 
rpm for 20 min. The supernatant was aspirated, the pre-
cipitate washed with 1 ml PBS, centrifuged and the super-
natant aspirated again~ Finally the precipitate was counted. 
The relative percentage bound was calculated as follows: 
relative % bound B - Bbl X 100% 
BO - Bbl 
B percentage bound (counts precipitate per total counts 
added) 
B0 percentage bound obtained in tubes containing no 
reference preparation or sample 
Bbl= percentage precipitated counts in tubes containing no 
reference preparation or sample and no antiserum 
The amount of LH or FSH in unknown samples was estimated 
by comparing the relative percentage bound -of the unknown 
sample with the amount of reference preparation at the same 
relative percentage binding. 
Criteria. 
The specificity of the RIA system was studied by comparing 
the dose response curves of a number of rat pituitary pre-
parations with varying biological potencies of LH, FSH and 
TSH. An RIA system was considered as specific e.q. for LH, 
if the ratios of the amounts of these preparations required 
to achieve 50% relative binding was similar to the ratios 
of their biological LH activities and if hormone-free serum 
gave no displacement. 
The sensitivity of the RIA systems was defined as the 
amount of hormone required to achieve 90% relative binding. 
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2-2-4 Radioimmunoassay of rat LH. 
OR rat LH RIA. 
An antiserum with a high binding capacity for rat LH was 
obtained by immunizing rabbits with ovine LH. For this 
purpose NIH-LH-S-17 was used which was available in suffi-
cient quantity. Since an RIA system is generally more 
reliable when the hormones competing for the antibody are 
of the same species, an OR rat LH RIA was developed with 
NIAMD-rat-LH I-1 as the labelled hormone. 
Six rabbits were immunized by intracutaneous injections 
of 150-200 ug NIH-LH-S-17 per animal. This amount was dis-
solved in 0.3 ml 0.9% NaCl solution, emulsified in 0.7 ml 
complete Freund's adjuvant and injected at different sites 
on the back. The injections were given 3 times at 3-weeks 
intervals. Ninety days after the last injection a booster 
injection of 1 mg NIH-LH-S-17 dissolved in 0.5 ml 0.9% NaCl 
solution with 0.5 ml complete Freund's adjuvant was given 
intracutaneously. Ten days later blood was collected from 
the ear vein for estimation of antibody titer. Thereafter 
booster injections were given every month. A serum with a 
high antibody titer (anti-ovine-LH 610 V) was selected for 
further study. The antibody was used in an initial 
Table 2-1 Radioimmunoassay of rat LH. 
Influence of FSH and TSH on rat LH determination in an RIA system 
(OR rat LH RIA) with NIAMD-rat-LH I-1 1251 as tracer and anti-ovi.ne 
LH (610 V, 1/70000) as antiserum. FSH/LH and TSH/LH reflect the 
ratios of biologically assayed FSH (expressed as mg NIH-FSH -81), 
respectively TSH (expressed as USP TSH) to LH (expressed as mg 
NIH-LH -Sl). 
bioa$soy immvnoa»ay 
preparation O.A.A.D. HCG-AUGM. McKenzie FSH TSH immvno potency relative 
tested NIH-LH-SJ NIH-FSH-S 1 USP TSH lH lH to NIAMD-rot-LH 1-l 
NIAMD-rat-LH RP-1 0.03 0.54 0.22 18 7.3 0.02 
NJAMD-rat-LH I-I 1.0 <0.04 0.4 <0.04 0.4 e J 
NIAMD-"rat-FSH RP- J 0.02 2.1 0.3 lOS IS 0.01 
NIAMD-rat-FSH 1-1 <0.002 :- 100 >50000 <0.003 
NIAMD-rot-TSH 1-1 0.02 <0.1 35 <S 1750 0.1 
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Fig. 2-1 Dose response curves of rat pituitary preparations and serum in an 
RIA system (OR rat LH RIA) with NIAMD-rat-LH 1-11251 as tracer 
and anti-ovine LH (610 V, 1/70000) as antiserum. 
concentration of 1 to 70.000 resulting in a binding of 
approximately 25%. 
Data on the specificity of this antibody for rat LH are 
given in Table 2-l. The dose response curves of a number of 
rat pituitary preparations with widely varying ratios of LH, 
FSH and TSH as known from bioassay data provided by the 
NIAMD tun parallel except for that of NIAMD-rat-FSH I-1 
(Fig. 2-l). The immunopotencies of these preparations were 
calculated relative to NIAMD-rat-LH I-1. Notwithstanding 
the extreme FSH/LH and TSH/LH ratios, the immunopotencies 
of these preparations were close to the LH bioassay data. 
Only in the preparation with a very high amount of TSH 
(NIAMD-rat-TSH I-l) was a five-fold higher LH immunopotency 
observed. Since such high TSH concentrations are only present 
in purified pituitary preparations it has been assumed that 
within the physiological range, interference by FSH and TSH 
is neglic;rible. 
The influence of serum was studied by comparing dose 
response curves of various sera with the rat pituitary 
standard. Although the dose response curve of the serum of 
a spayed rat seemed to run parallel to the rat standard 
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Table 2-2 Comparison between different RIA systems for rat LH. 
LH* estimated in standard serum (10-S) 
100 ).ll 200 JJI 
~ 
sensitivity** coeff. of coeff. of 
assay system mean+ S.D. N mean+ S.D. voriation***N mean+ S.D. variation N 
00 rot LH RIA 0.79 ~ 0.34 40 ~ 7.5 18.7% 37.2 + 5.1 14.7% 
RR rat LH RIA 16.6 ~ 2.5 7 N.D. 95.0 + 22.7 24 % 7 
OR rot LH RIA 2.65 ~ 0.34 14 31 ~ 3.6 11.5% 14 31.7 ~ 4.5 14.3% 14 
* expressed in ng N!AMD-rat-LH RP-1/ml serum 
~~ ng NlAMD-rat-LH RP-1 calculated at 90% relative binding 
**"'coefficient of variation"'~ x 100",6 
mean 
curve, repeated assays of this serum showed a significantly 
higher LH concentration at 100 ~1 (295 ~ 5.1 ng rat-LH RP-
1/rnl) than at 50 "l (275 ~ 4.5 ng rat-LH RP-1/rnl). Also 
serum of a hypophysectomized animal showed slight dis-
placement of iodinated rat LH from the antibody. This 
indicates that a serum component cross reacted with LH for 
the anti-ovine LH serum. 
The sensitivity of this assay system is 2.65 ng rat-LH 
RP-1 ·(90% relative binding), which is six times higher than 
that of the RR rat LH RIA (Table 2-2). 
In a standard serum (10-S) an LH concentration equivalent 
to 31 ng/ml (coefficient of variation 11.5%) and 31.7 ng/ml 
(coefficient of variation 14.3%) was estimated when assayed 
at dose levels of 100 and 200 ~1 respectively. These results 
agree with the data obtained with the very sensitive 00 rat 
LH RIA of Niswender et al (1968a) (Table 2-2). 
RR rat LH RIA. 
This system made available by the NIAMD has been described 
by Monroe et al (1968). It was used for the serum LH deter-
minations in the PMSG experiments (chapter 5) . As already 
mentioned above the sensitivity of this systew is low (16.6 
ng NIAMD-rat-LH RP-1 at 90% relative binding). The LH in the 
standard serum (10-S) could only be detected at a dose level 
of 200 ~1 and resulted in an LH concentration of 95 ng/ml 
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(coefficient of variation 24%}. This estimated concentra-
tion of LH is two to three times hicrher than that obtained 
with the OR and 00 rat LH RIA (Table 2-2) . This is in 
contrast with the observations of Niswender et al {1968a) 
and Monroe et al (1969), who observed that estimates of LH 
potency obtained with the 00 and RR rat LH RIA systems were 
in good agreement. Hence, in our hands the RR rat LH RIA 
appears to overestimate the true LH values. 
2-2-5 Radioimmunoassay of rat FSH. 
This system has been described by Daane and Parlow (1971). 
Since its distribution by the NIAMD, it has been employed 
for measuring serum FSH in rats by many investigators. 
Data on the specificity of this assay system for rat FSH 
are given in Fig. 2-2 and Table 2-3. The dose response curves 
of three rat pituitary preparations (rat-FSH RP-1, rat-LH 
RP-1 and the highly purified rat-FSH I-1) run parallel and 
the iromunopotencies, as calculated from these curves, rela-
tive to NIAMD-rat-FSH RP-1 were close to the FSH bioassay 
data of these preparations. However, in the purified rat 
pituitary preparations with high ratios of LH/FSH (rat-LH 
rei.% bound 
wo 
NIAMD-rot-FSH 1-1 
0.01 0.1 
ng nondord or vi •ervm 
Fig. 2-2 Dose response curves of rat pituitary preparations and serum in an 
RIA system (RR rat FSH RIA) with NIAMD-rat-FSH 1-11251 as tracer 
and NIAMD-anti-rat-FSH Sl (1/875) as antiserum. 
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Table 2-3 Radioimmunoassay of rat FSH, 
Influence of LH and TSH on rat FSH determination in an RIA system 
(RR rat FSH RIA) with NIAl\ID-rat-FSH 1-11251 as tracer and NIA:MD-
anti-rat-FSH Sl (1/875) as antiserum, LH/FSH and TSH/FSH reflect the 
ratios of biologically assayed LH (expressed as mg NIH-LH-Sl). 
respectively TSH (expressed as USP TSH) to FSH (expressed as mg 
NIH-FSH-81). 
bioassay immunoa~say 
preparation O.A.A.D. HCG-AUGM. Mo;:Kenzie LH TSH immune poteno;:y relative 
tested NIH-LH-Sl NIH-FSH-S 1 USP TSH FSH FSH to NIAMD-rot-FSH RP-1 
NIAMD-rat-LH RP- I 0.03 0.54 0.22 0.06 0.4 0.60 
NIAMD-rat-LH 1-1 }.0 <0.04 0.4 >25 >lO 0.27 
NIAMD-rot-FSH RP- I 0.02 2.} 0.3 0.01 0.14 "'2. I 
NIAMD-rat-FSH 1-1 <0.002 + 100 <0.00002 93 
NIAMD-rat-TSH 1-1 0.02 <0.1 35 >0.2 >350 ~ o.s 
I-1) or TSH/FSH (rat-TSH I-1) cross reactions with LH and 
TSH were found. These results are in agreement with those 
of Seki ~ al (1971), who demonstrated qood correlations 
between the FSH potency of pituitary extracts estimated by 
bioassay and by this RIA system. 
An influence of serum has been reported by Swerdloff et al 
(1971) and Seki ~ al (1971). They demonstrated that the 
binding of the labelled hormone to the antibody was signific-
antly inhibited when serum from hypophysectomized rats was 
added to the FSH assay. We also observed non-specific inter-
ference of serum. When sera with high FSH concentrations 
were measured at two dose levels lower FSH concentrations 
were found at 200 vl than at 100 vl, suggesting a partial 
inhibition of the displacement reaction in the presence of 
more serum. For this reason all serum samples were assayed 
at a constant serum volume of 100 vl. 
The sensitivity of the FSH assay was 26.3 ng NIAMD-rat-
FSH RP-1 (90% relative binding). This means that FSH con-
centrations below 200 ng FSH RP-1/ml are undetectable when 
100 vl samples are used. For this reason FSH could only be 
detected in the standard serum (10-S) at a dose level of 
200 vl (FSH concentration 174 nq NIAMD-rat-FSH RP-1/rnl, 
coefficient of variation 18.4%). 
30 
chapter 3 
Ovarian activity in adulthood after neonatal administration 
of a high or a low dose of testosterone propionate 
3-1 Introduction. 
A single injection of TP in neonatal female rats may 
prevent ovarian cyclicity in adulthood (Barraclough, 1961; 
Gorski and Barraclough, 1963). In these studies the effect-
iveness of neonatal androgen treatment was established at 
one age only (usually 10 or 20 weeks) using the occurrence 
of prolonged vaginal cornification and the absence of 
corpora lutea in the ovaries as criteria. The dosage used 
by Barraclough (1961), 1250 Vg TP on day 5, was effective 
in all the animals injected. When lower doses were used (5 
or 10 vg TP on day 5) it was found that the incidence of 
anovulatory ovaries depended on the age at which the ovaries 
were examined. The proportion of anovulatory rats rose 
between the ages of 10 and 21-24 weeks (Swanson and van der 
Werff ten Bosch, 1964a}. These observations indicated that 
with a small dose of TP some animals showed ovulatory cycles 
for some time after puberty, but stopped cycling at a later 
age while with a large dose of TP the animals became 
anovulatory earlier. 
In order to study the development of the early-androgen 
syndrome in rats treated with a high dose of TP and in rats 
treated with a low dose of TP, it was necessary to study 
the extent to which a low dose of 1250 ~g TP given on day 
5 or 5 ~g TP given on day 5 would affect ovarian cyclicity 
in our strain of rats (the R-Arnsterdarn substrain). 
3-2 Experiment and results. 
Female rats of the R-Amsterdam substrain were injected 
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on day 5 either ·with oil or with 5 or 1250 ~g TP. Vaginal 
smears were made daily from day 50 till day 120. Thereafter 
some animals were killed for inspection of the ovaries. 
All female rats treated with 1250 ~g TP were anovulatory 
during the entire period studied as judged from the vaginal 
smears. These smears always contained cornified cells 1 
sometimes mixed with non-cornified epithelial cells or 
leucocytes but cyclic variations, which in normal rats are 
indications of ovulation and corpus luteum formation, were 
lacking. At autopsy it appeared that the ovaries contained 
follicles and interstitial tissue, but no corpora lutea. 
In addition to follicles capable of ovulating with exogenous 
gonadotrophins (see chapter 6) , many atretic follicles were 
present. Vaginal smears of the majority of the low dose TP-
treated animals showed regular oestrous cycles from day 50 
till day 60. No differences between low dose TP-treated 
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Fig. 3-1 Percentage of rats showing per.sistent vagi.n.al cornification (PVC) as 
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a function of age in a group of 74 rats treated 'With 5 pg testosterone 
propionate on day 5 • PVC has been defined as the beginning of a period 
of at least one sequence of 10 consecutive days with cornified smears. 
rats and oil-treated rats were found in this period. 
However, with increasinq age the cycles became irregular, 
sometimes with prolonged oestrous periods eventually result-
ing in persistent vaginal cornification (PVC) in nearly all 
animals. In Fig. 3-1 the percentaqe of rats showing PVC is 
qiven from day 50 till day 120. The ovaries of animals killed 
while vaginal cycles were normal contained follicles and 
corpora lutea. The ovaries of animals killed during the 
period of PVC contained exclusively follicles. No fresh 
corpora lutea were found. 
In conclusion it can be said that high dose TP-treated 
rats were anovulatory at any time studied while most of the 
low dose TP-treated rats became anovulatory after a period 
of spontaneous ovulatory cycles. These findings are similar 
to those described earlier (Swanson and van der Werff ten 
Bosch, l964a,b). In the R-Arnsterdarn substrain the majority 
of the 5 ~g TP-treated rats became anovulatory between 70 
and 90 days of age. 
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Chapter 4 
Serum gonadotrophins and follicular development during 
the prepuberal period and the onset of puberty in female 
rats after neonatal administration of testosterone propionate 
4-1 Introduction. 
During the prepuberal period of the female rat several 
maturational processes take place in the brain, the hypo-
physis and the ovaries resulting in ovulation and oestrous 
cycles (for reviews see Donovan and van der Werff ten Bosch, 
1965; Critchlow and Bar-Sela, 1967; Meijs-Roelofs, 1973). 
In the hypophysis LH and FSH are present at birth. The 
LH content reaches maximal values in the period between 
days 30 and 40 (Lisk, 1968; Suzuki et al, 1971), while the 
FSH content reaches maximal values around day 25 (Corbin 
and Daniels, !967; Kragt and Ganong, 1968; Watanabe and 
McCann, 1969; Suzuki et al, 1971). LH and FSH are present 
in the blood long before puberty occurs. The serum FSH 
concentrations reach a peak value on day 15 and decline 
after day 21 (Kragt and Dahlgren, 1972; Ojeda and Ramirez, 
1972; Meijs-Roelofs et al, 1973b). 
In the brain hypothalamic mechanisws regulating gonado-
trophin release develop. An inhibitory ovarian feedback on 
gonadotrophin release is operative shortly after birth 
(Goldman and Gorski, 1971; Caligaris et al, 1972; Meijs-
a Roelofs et al, 1973 ) . The presence of a stimulatory feedback 
action of ovarian steroids on gonadotrophin release can be 
demonstrated from day 20 onwards (Caligaris et al, 1972, 
1973) . 
In the ovaries a number of follicles start to grow between 
birth and day 10. Thereafter growth continues and small 
antral follicles appear. The follicles increase in volume 
to large antral follicles after day 20 (for review see 
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Critchlow and Bar-Sela, 1967). 
The question arises as to how these maturational processes 
develop after neonatal administration of TP. Data on the 
influence of neonatal androgen on the various maturational 
processes during the prepuberal period are limited. Compared 
to normal rats ovarian weights of androgenized rats were 
lower 10 days after a single injection of 1500 ~g TP on day 
5 (Jacobsohn, 1964) and after an injection of 100 ~g TP 
(Matsuyama et al, 1966). In mice, Peters et al (1970) 
observed a reduced number of small oocytes in the ovaries 
two days after injection of 1 mg TP on day 5 and a reduced 
number of growing follicles at 28 days of age. Pituitary 
LH content was lower than in normal rats on days 15, 21 and 
28 ( 100 ~g TP on day 5; Matsuyama et al, 1966) and day 30 
(1250 ~g TP on day 5; Barraclough, 1966b). Serum LH concen-
trations lower than those in untreated rats have been found 
by Weisz and Ferin (1970) on days 7 to 21 (100 ~g TP on day 
5) and lower serum FSH concentrations by Johnson (1971) on 
day 30 and thereafter (50 ~g TP on day 5). 
In androgen-treated rats as compared to normal rats the 
first cornification of the vagina occurs earlier (Jacobsohn, 
1964) and uterine weights before "puberty" are higher 
(Johnson, 1972). Therefore, it has been assumed that early-
androgen administration accelerates sexual maturation (van 
der Werff ten Bosch et al, 1971). 
In order to study the influence of neonatal administration 
of TP on sexual maturation prepuberal serum levels of FSH 
and LH, follicular development and the age at which vaginal 
opening, first oestrous smear and first ovulation occurs 
are studied in rats treated with either a low or a high 
dose of TP. 
4-2 Experiments and results. 
4-2-1 Effect of neonatal administration of TP on serum 
gonadotrophins and follicular development during 
the prepuberal period. 
35 
Female rats of the R-Amsterdam substrain were injected on 
day 5 with oil, 5 ~g TP or 1250 ~g TP between 09.00 and 
10.00 hrs. Six litters of each treatment group were formed, 
each consisting of 8 animals. Starting on day 5 and continu-
ing on every fifth day till day 35, one animal of each 
litter was killed at 15.00 hrs. Blood was collected for LH 
and FSH determination. Body weight, ovarian weights and 
vaginal opening were recorded at autopsy. Ovaries were 
fixed in Bouin's fluid, sectioned at 5 ~ and serial sections 
were mounted for counting follicles. 
Follicular volumes were determined by the method of Boling 
et al (1941), modified in two ways: (1) two diameters were 
measured in the section in which the nucleolus of the ovum 
was found. ( 2) the third diameter was substituted by the mean 
of the two other diameters. Only follicles with a volume 
exceeding 100 x 10 5 ~rn3 were counted in order to compare the 
results with those obtained in a previous study in untreated 
prepuberal rats (Meijs-Roelofs et al,l973b). These follicles 
are all antral follicles, and their incidence varies during 
the oestrous cycle in adult rats (Mandl and Zuckerman, 1952; 
Welschen, 1973). Three categories were distinguished: (1) 
5 3 5 3 5 100 - 249 X 10 "In (2) 250 - 499 X 10 "m , (3);. 500 X 10 
3 ~m . In the oestrous cycle follicles of the last category 
will ovulate after HCG treatment (Welschen and Rutte, 1971) 
To establish the numbers of follicles, rats with ovaries 
containing corpora lutea have been excluded. 
Both FSH and LH were measured in peripheral blood of 
individual animals except for animals younger than 10 days 
of age, in which case blood from 2 to 10 animals was pooled. 
An additional group of similarly treated animals was used 
for blood collection till day 10. Serum LH was determined 
by the OR rat LH RIA, serum FSH by the RR rat FSH RIA. 
Serum samples were assayed in duplicate in an aliquot of 
100 ~1. LH concentrations are expressed in ng NIAMD-rat-LH 
RP-1/rnl, FSH concentrations in ng NIAMD-rat-FSH RP-1/ml. 
Data on body weight, ovarian weights and uterine weight 
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Table 4-1 Body weight, ovarian and uterine weights of female rats treated on day 
5 with oil, 5 or 1250 ~g testosterone propionate (mean+ S.E.M.). 
treatment ,,. vaginal opening* no. of body weight ovarian weights uterine weight 
on day 5 (days) rats (g) (mg) (mg) 
oil 6 9.5 ::: 0,2 0.47 + 0.03 2.22::0.16 
10 17.2 + 1.0 1.32 + 0.18 6.27::: 0.99 
15 6 27.8+ 1.2 3.37 + 0.30 16,6 + 1.2 
20 6 38.2::: 1.5 7.49 + 0.17 19.1 + 0.9 
25 6 46.9:: 1.3 14.1 + 0.2 20.0 ::-0.8 
30 6 64.4 + 2.2 17.7 + 0.5 32.4 + 1.6 
35 6 84.4::: 2.3 22.0 + 0.5 54.0 + 5.5 
5 iJg TP 5 6 8.5 + 0.2 0.38 + 0.03 1.96:: 0.09 
10 7 15.7:: 0.8 1.05:: 0.07 5.33:: 0.34 
15 6 26.4 + 0.5 3.17 + 0.18 15.1 + 0.7 
20 6 40.2 ::- 1,5 8.06 + 0,94 21.9 + 1.0 
25 6 46.8 + 2.7 14.1 + 0.7 20.1 :: 1.2 
30 6 63.8:: 2. J 18,3 + 0.7 32.8 + 1.6 
2 85.3 + 2.2 21.4 + 0.3 69.5 + 30.5 
35 
' 
2 86.8::1.7 22.0 + 0.8 96,0 + 0.8 
85.0:: 2,5 26,5 + 4.8 129.7 :: 18.0 
1250JJg TP 10.0 + 0.2 0.49 + 0.05 2,55::0.12 
10 8 16.9::0.6 0.98 + 0.04 5.43:: 0.34 
15 6 27.5 :: 1.0 1.72;!:0.17 10.4 ;!:0.5 
20 7 38.1 :: 1.1 4A5:t226 17.5 + 0.9 
25 6 49.0 + 1.4 12.4 !02 19.6 + 0.9 
{ p"m~ole 63.7::1,9 15.7 + 0.4 34.2 ::4.4 30 70.5:: 2.8 16.5 + 0.2 39,5 + 0.8 
{ pin:ole 3 86.5 :: 3.3 19.1 +2.7 79.2 :: 13.4 
35 99.3:: 8.6 24.5 ::3.0 154,7 :: 10.1 
• vaginal opening is indicated by: -(closed vagina),± (partial vaginal opening),+ (open vagina) and 
"pinhole" (small vaginal opening in a flat vaginal membrane) 
bold face means significantly different from the corresponding oil-treated group (P<0.05 Student's t-test) 
statistics were not performed in groups smaller than 5 animals 
are given in Table 4-1. 
On day 35 the condition of the vagina appeared different 
in the three treatment groups. Since in the normal female 
rat differences in vaginal development reflect differences 
in maturational stage, the data of rats killed at day 35 
have been subdivided according to the state of vaginal 
development. Oil-treated animals had a closed vagina on day 
35. Two of the six 5 ~g TP-treated rats had a closed vagina, 
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two rats showed an indication of vaginal opening such as is 
usually seen in normal rats on the day before first ovulation 
and two rats showed a well developed, open vagina. In the 
rats treated with 1250 ~g TP vaginal development was ab-
normal. As early as day 30, 3 out of 6 animals showed a 
"pinhole" in a flat vaginal membrane, while on day 35, 3 
out of 6 animals had an open vagina and the remaining three 
the 11 pinhole" type of vaginal opening. 
Body weights of the three treatment groups were not 
different during the period studied. 
Ovarian weights of oil- and 5 ~g TP-treated animals were 
not different. On days 15,20, and 25 ovarian weights 
of the 1250 ~g TP-treated groups were significantly lower 
than those of both control and 5 ~g TP-treated animals. 
Uterine weights of all rats increased till day 20, then 
remained constant till day 25 and increased further with a 
sharp rise in weight at vaginal opening. No differences 
were found between the different treatment groups, except 
on day 15, when in 1250 ~g TP-treated rats a lower uterine 
weight was recorded and on day 35, when uterine weights of 
TP-treated rats were higher than in control rats. 
The results of follicular measurements are given in 
Table 4-2. In oil-treated rats the first follicles of the 
category 100 - 249 x 10 5 ~m3 appeared on day 20. On day 25 
their number had increased and a maximum was reached on day 
30. Follicles of the second volume class (250 - 499 x 10 5 
~m3 ) appeared on day 25 and remained constant in number 
till day 35. Large follicles (¢ 500 x 10 5 ~m3 ) were only 
occasionally found. In the 5 ~g TP-treated rats the pattern 
was essentially the same. Only the numbers of small follicles 
(100 - 249 x 10 5 ~m3 ) were slightly smaller during the period 
studied. In the 1250 ~g TP-treated rats the pattern was 
different. Significantly smaller numbers of the small follicles 
were present on days 20 and 30, while on day 35 follicles 
)500 x 10 5 ~m3 were present in a significantly higher 
nwnber than in the two other treatment groups. 
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Table 4-2 NlUilbers of follicles of various vollUile classes in one ovary of rats 
treated on day 5 with oil, 5 or 1250 p.g testosterone propionate, 
NlUilbers in parentheses are nlUilbers of animals, 
Follicular treatment mean num ers o 0 "' '" 
b f f II' I s. l a vary (+ S EM) .. 
-
volume on day 5 day 15 day 20 day 25 day 30 day 35 
oil - 2.5:: 0.8 (6) 11.6::1.9(5) 16.2:: 1.2 (6) 10.8::2.9 (5) 
100- 249 5 J.l9 TP - 2.0:: 0.5 {6) 9.2:: 1.1 {6) 15.5 :: 2.5 (6) 8.8:: 2.6 (4) 
x 105 j.Jm 3 1250JJgTP - 0.2 t0.2 (6) 9.3:: 1.4 (6) 9.2f 1.6{5) 8.2:: 1.2 (5} 
oil 
-
0.2 + 0.2 6.6 + 1.3 5.5 + 1.6 5.4+ 1.6 
250- 499 -
x 105 pm 3 
5 J.l9 TP - - 8.0 + 1.3 6.8:: 1.7 7.7 + 0.6 
l250JJg TP - - 7.0+1.1 7.4:: 1.5 5.8 + 1.5 
oil -
- 1.0 :: 0.4 - 1.0 + 0.5 
>500 5 J.Jg TP - - 1.0 :: 0.8 - 1.3 + 0.5 
x lOS ).lm 3 
1250 JJg TP - - 1.5 + 0.6 0.8 + 0.4 5.2 :t 1.3 
-
bold face mean significantly different from oil-treated group (P<O.OS Student's t-test) 
Sen~m FSH concentrations- measured in these animals, 
supplemented by data obtained on similarly treated rats 
killed at other ages, are presented in Fig. 4-1. In control 
animals serum FSH concentrations were lower on day 5 (500 
ng/rnl) than on days 10-15 (1000 ng/ml). Thereafter, values 
decreased g~adually to almost undetectable values on days 
30 and 35 (< 100 ng/rnl). Note that serum FSH concentrations 
measured with the same method during the oestrous cycle 
varied from 100 ng/ml at dioestrus to 500 ng/ml during late 
prooestrus and early oestrus. Following the day of injection 
(day 5) 5 ~g TP-treated rats showed lower serum FSH concentra-
tions on day 7 than control rats (290 ng/ml vs 597 ng/ml) 
From day 10 onwards the FSH concentrations were not 
different from those of control rats. Injection of 1250 ~g 
TP on day 5 resulted in lower FSH concentrations than in 
oil-treated control rats for a much longer period than in 
5 ~g TP-treated rats. The lowest concentration was found on 
day 9 (238 ng/ml). On day 20 the FSH concentrations were not 
different from those of the control rats. From this day on 
the FSH pattern was similar to that of oil- or 5 ~g TP-
treated rats. 
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Fig. 4-1 Serum FSH concentrations in prepuberal female rats treated on day 5 
with oil, 5 or 1250 pgtestosterone propionate (TP). Each point before 
day 10 represents the mean ( .:!:_ S.E. M.) of 2-4 pools of blood (2-10 ani-
mals). From day 10 onwards each point represents the mean (:!:. S. E. M.) 
of individual samples of 5-7 animals. 
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Fig. 4-2 Serum LH concentrations in prepuberal female rats treated on day 5 
with oil, 5 or 1250 p.g testosterone propionate ( TP). Each point 
represents one determination. Before day 10 pools were used of 2-10 
animals. On day 10 and thereafter samples of individual animals were 
used. The curve represents the mean levels. 
41 
Serum LH concentrations are given in Fig. 4:....2. Control 
rats showed, in contrast to the regular FSH pattern with 
high levels before day 25, LH levels with much variation. 
The levels were generally low (< 100 ng/ml). 
Only on day 20 a few rats showed high LH concentrations. 
Note that serum LH concentrations during the oestrous cycle, 
measured with the same method, varied from <50 ng/ml in 
dioestrus to >1000 ng/ml during late prooestrus. In 5 and 
1250 ~g TP-treated rats serum LH concentrations were also 
low. An influence of neonatal TP on serum LH could not be 
detected. 
Body weights, ovarian weights, uterine weights and serum 
gonadotrophin levels of oil-treated animals are in agreement 
with the data obtained in a previous study in untreated rats 
(Meijs-Roelofs et al, 1973b). Also the measurements of 
follicular development are essentially the same. 
4-2-2 Effect of neonatal administration of TP on the onset 
of puberty. 
This experiment was carried out to investigate more system-
atically the time of puberty in TP-treated rats. 9 Animals 
of each treatment group were inspected daily to see whether 
the vagina was open.From the day of vaginal opening vaginal 
smears were taken daily for about 10 days. Then the animals 
were killed at oestrus and the number of tubal ova counted. 
Table 4-3 Effect of neonatal administration of testosterone propionate on vaginal 
opening and ovarian function (mean.:!:. s. E. M.). 
vaginal opening and rats with 
treatment number of "pinhole" vagina at first oestrous smear ot oestrous cycles number of ova 
on day 5 animals age (days) body weight (g) age (days) b.w. (g) days 38-48 at oestrus 
ail 9 38.2 ~ 0.5 89.9~3.1 100% 10.5 ::- 0.4 (6) 
5 j.Jg TP 9 37.7 + 0.4 89.6 + 3.6 100% 10.0 ~ 0.2 (6) 
12501.19 TP 9 31.3 ~ 0.2 63.1 + 1.0 38.2::: 0.4 93.3 + 1.8 O% 
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The results are given in Table 4-3. In oil-treated 
animals vaginal opening occurred at 38.2 days of age at a 
mean body weight of 89.9 g. All these animals showed a 
cornified vaginal smear on the day of vaginal opening. In 
5 ~g TP-treated rats vaginal opening and first observed 
vaginal cornification occurred at an age (37.7 days) and 
body weight (89.6 g) not different from those of oil-
treated rats. Note that in the previous experiment the 
vaginal development of the 5 ~g TP-treated rats was slightly 
accelerated. All 5 ~g TP-treated animals showed regular 
5-day cycles between days 38 and 48. The number of ova of 
these animals, killed at oestrus, were also similar to those 
of oil-treated rats. In 1250 ~g TP-treated rats an abnormal 
vaginal development was observed. As in the previous 
experiment, a small hole was seen in a flat vaginal membrane 
(a "pinhole" vagina) at an early age (31.3 days) and at a 
low body weight (63.1 g). The vaginal smears taken daily 
from this npinhole" vagina showed only a few epithelial 
cells and a few leucocytes without daily changes till, at 
an age of 38.2 days and a body weight of 93.3 g, not 
different from those of oil- and 5 ~g TP-treated rats, the 
vaginal opening increased to normal size. From this day on 
the vaginal smears were continuously cornified. At autopsy 
10 days later the ovaries contained no corpora lutea. 
4-3 Discussion 
Following TP administration on day 5 a decrease in serum 
FSH concentration has been seen. Goldman and Gorski (1971) 
found decreased serum FSH concentrations 8-9 hrs after a 
single dose of TP on day 6 or after a single injection of 
OB on day 5 or 7. The present data show that the fall is 
temporary and presumably due to an inhibitory action of the 
injected TP. The existence in female rats of an inhibitory 
steroidal feedback before day 20 has been demonstrated for 
oestrogen in a previous report (Meijs-Roelofs ~ al, 1973a). 
In that study it was shown that ovariectomy on day 13 
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resulted in an increased FSH level two days later as compared 
to the control value. This increase was not observed when 
ovariectomy was followed by daily injections of 0.1 ~g 
OB/100 g body weight. 
The high FSH concentrations found in normal rats before 
day 20 may be of importance for follicular growth. This vie;N 
is in agreement with findings of Eshkol et al (1970) who 
observed in mice a decreased follicular cell proliferation 
and organization at 7 and 14 days of age after daily 
injections of anti-gonadotrophic serum given from the day 
of birth. When FSH was given together with anti-gonadotrophic 
serum the follicular cell proliferation appeared normal. 
Fig. 4-3, which depicts the data on serum FSH concentrations 
and on numbers of follicles, shows for control rats a serum 
FSH peak on days 10-15 and a peak in the number of antral 
follicles in the volume class of 100 - 249 x 10 5 ~m3 on day 
30. In the mouse the development of primordial follicles 
to antral follicles takes about 12-16 days (Pedersen, 1969). 
If the rat ovary undergoes changes parallel to the ovary of 
the mouse, the high FSH concentration around day 12 might 
stimulate massive growth of primordial follicles. The absence 
of the FSH peak in the 1250 ~g TP-treated rats might then 
result in the reduction of the number of antral follicles 
in the volume class of 100 - 249 x 10 5 ~m3 noted on day 30. 
Another explanation is given by Peters et al (1970). These 
authors found after injection of 1000 ~g TP in day 5 old mice 
a reduction in the number of growing follicles on day 28. 
They suggested that this effect was due to an accelerated 
reduction of the number of small oocytes observed two days 
after TP administration. 
The reduction of the number of small follicles (100 - 249 
x 10 5 ~m3 ) may be reflected in the lower ovarian weights 
on day 20 and thereafter following injection of 1250 ~g TP. 
The lower ovarian weights before day 20 are probably caused 
by a reduction in the number of follicles < 100 x 10 5 ~m3 
The low uterine weight in the 1250 ~g TP-treated rats on 
day 15 suggests a low oestrogen concentration in the blood 
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Fig. 4-3 Serum FSH concentrations and numbers of follicles of various volume 
classes in one ovary in prepuberal female rats treated on day 5 with 
oil or 1250 pg testosterone propionate. 
in these rats. Such a low oestrogen concentration together 
with the observed decreased FSH concentration might also 
explain the retarded follicular growth. Goldenberg et al 
(1972) demonstrated that oestrogen increases both granulosa 
proliferation and incorporation of FSH in the follicles and 
in this way stimulates follicular growth. In addition Reiter 
et al (1972) found a significant decrease in follicular 
growth in immature rats treated with specific anti-oestradiol 
serum for periods of 4 days. 
On day 35 the ovarian development in the rats treated with a 
high dose of TP seemed to be accelerated. Follicles in the 
5 3 largest volume class (~ 500 x 10 ~m ) were present in a signi-
ficantly higher number in the 1250 ~g TP-treated rats than in 
the 5 v9 TP- or oil-treated rats. Also uterine weights were 
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higher and the vaginal development had been accelerated. An 
earlier vaginal opening after neonatal TP-treatment has been 
described previously (Segal and Johnson, 1959; Tramezzani et 
al, 1963; Jacobsohn, 1964; Forsberg et al, 1966). Although 
this suggests an earlier sexual maturation, vaginal opening 
is not a useful index of sexual maturation in these rats, 
since it has been demonstrated that TP itself causes the 
breakdown of the vaginal orifice (Jacobsohn 1964, Jacobsohn 
and Norgren 1965). A "pinhole" vaginal opening was seen in 
our experiments at a very early age and at low body weight 
in rats treated with a high dose of TP. However, the vaginal 
opening increased to normal size and the first cornified 
smears were obtained at an age and body weight not different 
from that of oil- and 5 ug TP-treated rats. This latter 
finding is in contrast to that of other investigators, who 
observed cornified smears a few days earlier in TP-treated 
rats than in control rats (Jacobsohn, 1964: 1500 ug TP on 
day 5; Sheridan et al, 1973a: 1 ug TP daily for the first 
10 days of life). The presence of a higher number of large 
follicles on day 35 in the high dose TP-treated rats favours 
the concept of an accelerated sexual maturation. However, 
ovulation, which is in normal female rats, the culmination 
of sexual maturation cannot be achieved in high dose TP-
treated rats. Therefore the present finding indicates that 
an accelerated sexual maturation is limited to an accelerated 
follicular growth. 
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Chapter 5 
Induction of ovulation by PMSG in androgen-treated 
prepuberal rats 
5-1 Introduction. 
One of the maturational processes taking place in the female 
rat brain during the prepuberal period is the maturation of 
a mechanism for induction of ovulatory surges of LH. Such a 
mechanism is already present before puberty. Ovulation and 
corpus luteum formation can be induced by a single injection 
of OB (Hohlweg, 1934; DOrner and DOcke, 1964; Ying and Greep, 
1971a) or PMSG (Cole, 1936; Zarrow and Quinn, 1963). The 
ovulation inducing effect of these agents is mediated by an 
endogenous ovulatory LH surge on the second day after ad-
ministration of OB or PMSG. This was demonstrated by well-
timed pentobarbital administration (Ying and Greep, 1971b, 
in OB-treated rats; Strauss and Meyer, 1962; McCormack and 
Meyer, 1962, in PMSG-treated rats) and by direct measurements 
of serum LH (Ying ~ al, 1971 in OB-treated rats; Ying and 
Meyer, 1972; Sorrentino et al, 1972 in PMSG-treated rats). 
The presence of the mechanism inducing ovulatory surges of 
LH can be demonstrated from day 20 onwards. From that age 
on, ovulation can be induced by OB {Yinq and Greep. 1971b} 
or PMSG (Zarrow and Quinn, 1963; McCormack and Meyer, 1964) 
and a rise in serum LH can be induced by administration of 
progesterone to OB-primed rats (Caligaris et al, 1972). 
It is not known whether the development of this brain 
mechanism is disrupted by neonatal treatment with androgen. 
In the previous chapters it was shown that early administra-
tion of a sinale large dose of TP causes the anovulatory state 
from the time of vaginal opening, while a single swall dose 
(5 ~g TP on day 5) causes the anovulatory state after an 
initial period of ovarian cyclicity. Brown-Grant et al (1964) 
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demonstrated that no ovulation could be induced with P~SG 
in 30 day old rats, which had received 1250 ~g TP on day 4. 
Also, DOrner and DOcke (1964) could not obtain corpus luteurn 
formation after an injection of OB in rats treated with 1250 
~ q TP on day 3 . 
In this chapter the effects of PMSG administration to TP-
treated prepuberal rats were studied to answer the following 
questions. 
1) Can ovulation be induced with PMSG in animals treated 
neonatally with.a low dose of TP? 
2) Is the response to PMSG comparable to that in control 
rats? 
3) If not, is the difference from normal animals due to 
changes in the mechanism controlling the release of LH 
or to a change in ovarian responsiveness? 
4) Furthermore, is there a shift in the response to different 
doses of PMSG or in the age at which maximal response 
occurred that could be attributed to an acceleration of 
sexual maturation? 
A part of this study has been published in the Journal of 
Endocrinology (Uil~nbroek and van der Werff ten Bosch, 1972). 
5-2 Experiments. 
5-2-l Effects of PMSG. 
Female rats of the R-Amsterdam substrain were injected on 
day 5 with oil, 5 or 1250 ~a TP. On day 30 all animals 
received 30 IU PMSG between 09.00 and 11.00 hrs. Body weights 
ranged from 65 to 70 g. Three groups of animals (A, B and C) 
were formed each consisting of oil, 5 or 1250 ~g TP-treated 
rats. Group A and B were killed on day 30, 31, 32 or day 33 
between 11.00 and 13.00 hrs. 
From group A body weight, ovarian wei~hts and uterine weia~t 
were recorded. 
From Group B the adenohyphophysis was dissected, weiahe0 on 
a torsion balancP., qui ckJ,y f:rozen ann st.nren nt. -7.0°~ for 
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LH determination. 
From Group C blood was collected for serum LH determina-
tion on day 32 (two days after PMSG injection) at either 
14.00 hrs, 15.00 hrs, 16.00 hrs or 18.00 hrs. The animals 
were bled only once in order to keep any possible disturbance 
of the ovulatory response as small as possible. On day 33 ova 
in the fallopian tubes were counted. 
Prior to determination of the LH content the hypophyses were 
thawed and homogenized in 10 ml 0.01 M PBS (pH 7.6). The 
homogenates were then centrifuged for 15 win and the super-
natants stored at -20°C until assayed. LH concentrations were 
estimated by the OR rat LH RIA (see chapter 2) at three dose 
levels in appropriate dilutions. The amounts of LH are ex-
pressed in ~g NIAMD-rat-LH RP-1 per gland. 
Serum LH concentrations were estimated by the RR rat LH RIA 
(see chapter 2). This relatively insensitive assay system was 
chosen because in a pilot experiment it had appeared that the 
antiserum used in the RR rat LH RIA did not crossreact with 
PMSG. In contrast, the OR rat LH RIA was not able to dis-
criminate rat LH from the injected PMSG. This is of particular 
importance because the half-life time of PMSG is rather long 
(Parlow and Ward, 1961). Serum LH concentrations are expressed 
in ng NIAMD-rat-LH RP-1 per ml serum. Duplicate volumes were 
assayed at two different dose levels (100 and 200 ~1). 
Data on body weight, ovarian weights, uterine weiaht, 
adenohypophysial weight, pituitary LH content and ovulation 
response obtained in the three groups A,B and C are combined 
in Table 5-l. 
In control rats (oil-treated neonatally) the dose of 30 IU 
PMSG uniformly resulted in ovulation with an average number 
of 10.1 ova per animal. In rats treated with 5 vg TP 33% of 
the animals responded to 30 IU PMSG, whilst the average number 
of ova per ovulating rat was 2.9. Animals treated with 1250 
~g TP did not ovulate in response to 30 IU PMSG on day 30. 
ovarian weights increased rapidly in all three treatment 
0roups (oil, 5 and 1250 ~g TP) followtnq PMSG administration. 
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Table 5-l Body weight, ovarian weights, uterine weight, adenohypophysial weight, pituitary LH content 
and ovulation response after administration of 30 IU PMSG on day 30 in rats treated on day 5 
with oil, 5 or 1250 )lg testosterone propionate (mean ~ S, E, M,), Data combined from 3 
different experiments. Numbers in parentheses are numbers of animals. 
treatment ogo body weight ovarian weights uterine weight odenohyp. adenohyp. LH rot~ that ovulated ova per 
on day 5 (days) (g) (mg) (mg) weight (mg) content** (pg) number % ovulating rot 
oil 30 61.3~2.1 (7) 15,5 ~ 0,5 (7) 26,9 ~ 2.1 (7) 2.49 ~ 0.17 (5) 122 + 21 (5) 
31 64.7 :t 2.7 (6) 30.2~0.9 (6) 55.9 "t 5.3 (6) 2.83 ::- 0.15 (3) 113 + 17 (5) 
32 65.2 ::- 1.4 (9) 61.3::- 1.6 (9) 92.4 ::- 2.3 (9) 3.31 ::-0.06 (5) 134 ::- 17 {5) 
33 63,3::- 1.1 (6) 100,6:: 8,0 (6) 102.7::0.9 {6) 3.42 :: 0,06 (5) 95 + 15 (5) 27/27 100 10.1 + 1.3 
5 ~g TP 30 55,5:: 1.3 (4} 17.4:: 0,6* (4} 26.4:: 1.9 (4) 2.89::0.14 (5) 140:: 3 (5) 
31 60.5 :: 2.7 (6) 26.6:: 1.2* (6) 67.1::3.6 (6) 3.22: 0,10 (5) 143 + 11 (5) 
32 64.7:: 2.5 (6) 49,9: 1.4* (6) 89.8:: 3,4 {6) 3,35 :: 0.18 (5) 139 + 21 (5) 
33 92.5:: 5.2 {7) 111.5::5.2 (7} 3.62 :: 0.07 (5} 137:: 6* {5} 9/27 33 2.9 + 0,6 
1250 pg TP 30 63.7: 1.8 (6} 12.7:: 0.3* (6) 24.1 ::- 1.3 (6) 2.64::0.12 (5) 66!11*(4} 
31 64,0 : 1.5 (6) 24.9: 1.1* (6) 55.9:: 5;9 (6) 3.07:: 0.16 {5) 90 + 15 (5) 
32 68,7 : 1.8 {7) 52.9:: 1.8* (7) 100.3! 2S(7) 3,14::0.10 {4) 108 + 25 (5) 
33 69.7! 2.0 (6) 76.4:: 4,8* (6) 106.4:: 2.5 (6) 3.26::0,12 (4) 53: 10* (5} 0/29 0 
*significantly different from the corresponding oil-treated group (P"0,05 Student's t-test) 
** expre~ed in )Jg NIAMD-rat-LH RP-1 
However, ovarian weights of the two TP-treated groups were 
subnormal on days 31 and 32. The subnormal ovarian weights 
on day 33 in the group treated with 1250 ~g TP probably 
reflects the absence of corpora lutea in these rats. 
Uterine weights also increased following PMSG administration. 
No systematic differences appeared between the three treatment 
groups. 
Adenohypophysial weights increased in all three groups 
during the four days studied. Whether this is due to the PMSG 
injection is not known, since no saline injected animals were 
included. 
Hypophysial LH content remained constant in the control and 
5 ~g TP-treated groups. Between days 30 and 33 the LH content 
in the 1250 ~g TP-treated rats tended to be lower than in oil-
and 5 ~g TP-treated rats. However, only on days 30 and 33 the 
difference was significant. 
Serum LH concentrations in control animals were below the 
detectable level on days 30 and 31. On day 32, the day 
preceding ovulation, control animals showed an increase of 
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Fig. 5-1 Serum LH concentrations two days after administration of 30 IU PMSG on 
day 30 in rats treated on day 5 with oil, 5 or 1250 p.g TP. Each point 
represents the LH concentration of one individual animal. 
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LH during the afternoon with a mean maximal value of 431 
ng/rnl at 16.00 hrs (Fig. 5-1). The 5 and 1250 vg TP-treated 
groups did not show an increase of LH on day 32 between 
14.00 hrs and 18.00 hrs. 
It is concluded that the lowered ovulation response seen 
in the TP-treated rats on day 33 after PMSG administration 
on day 30 is due to a lowered release of LH on day 32. 
5-2-2 Effect of progesterone on PMSG induced ovulation. 
Progesterone injected two days after PMSG administration 
~as been reported to result in an increase of the ovulatory 
response (McCormack and Meyer, 1963, 1964). zarrow and Hurlbut 
(1967) obtained maximal effect of proqesterone with a single 
injection of 0.5-1 mg 48-56 hrs after administration of PMSG. 
It has been suggested that proqesterone acts on the neural 
rnachanisrn controlling ovulatory LH release (Kaasjaqer et al, 
1971; Taleisnik et al, 1970). Since this mechanism may be 
affected by neonatal TP-treatrnent it seemed important to 
establish whether progesterone could also increase the PMSG-
induced ovulation response in TP-treated rats. 
In this and the following experiments of this chapter 
female rats of the "Endo 11 substrain were used. Animals of 
the three treatment 
PMSG on 
groups 
day 28 
(oil, 5 and 1250 vg TP) were 
between 08.00 and 09.00 hrs. The given 30 IU 
body weight of the ani~als ranged from 50-70 g. On day 30, 
52 hrs after PMSG administration, animals of each treatment 
group received a single s.c. injection of 0.5 mg progesterone. 
The animals were killed the following morninq and the number 
of ova was counted. 
The results are criven in Table 5-2. A comparison is first 
made of the data obtained with PMSG alone in the substrain 
used in ~his experiment and those obtained in the substrain 
used in the previous experiment (Table 5-1 and Table 5-2). 
52 
Table 5-2 Effect of progesterone on induction of ovulation by 30 IU P:MSG on day 
28 (52 h before progesterone) in rats treated on day 5 with oil or 
testosterone propionate (TP). 
treatment progesterone rats that ovulated ova per ovulating 
on day 5 (0.5 mg) number % rat (mean":!: S.E.M.) 
oil 18/18 100 40.9 + 3.0 
5 ~g TP 5/14 36 2.6 + l.O 
1250 ~g TP 8/15 53 2.5 + 0.3 
oil + 21/21 100 34.6 + 3.0 
5 pg TP + 21/23 91 14.5 + 3.1~ 
l250>.~g TP 3/16 19 2.7 + 1.2 
* s·,gnificantly different from 5 >.Jg TP-treated rats without progesterone 
(P<0.01 Mann-Whitney U test) 
With both substrains all control animals ovulated in response 
to a dose of 30 IU PMSG given on day 28. The number of ova 
released per rat however, was considerably higher in the 
"Endo" substrain (40 .9 vs 10 .1). The response to PMSG obtain-
ed in 5 )Jg TP~·treated rats was low (36% ovulation, 2.6 ova/ 
ovulating rat) and not different from that obtained in the 
animals of the previous experiment (33% ovulation, 2.9 ova/ 
ovulating rat). Rats treated with 1250 IJg TP now also 
responded, althou~h the average number of ova per ovulatinq 
animal was small (53% ovulation, 2.5 ova/ovulatina rat). In 
contrast to the results obtained with R-Amsterdarn substrain, 
there was no difference between the two TP-treated groups. 
If PMSG was followed by progesterone, a different picture 
emeraed. Although proaesterone had no significant influence 
on the response of control rats, there was a marked effect 
upon the rats treated with 5 )Jg TP. Nearly all (91%) of 
these animals now ovulated and the number of ova reached an 
average of 14.5 per ovulating rat. Progesterone had no 
significant effect on the group treated with 1250 )Jg TP. 
Here the incidence of ovulation and the number of ova per 
ovulating rat remained very small (19% ovulation, 2.7 ova/ 
ovulatina rat) . 
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It is concluded that progesterone facilitated PMSG induced 
ovulation only in the 5 ~g TP-treated rats. In the 1250 ~g 
TP-treated group and the control group no increased ovu-
latory response could be obtained: in the latter probably 
because a maximum response had already been reached. In 
comparison with the R-Amsterdam substrain, the "Endo" sub-
strain responded with a much hi?her number of ova. However, 
after neonatal TP-treatment the response to PMSG was very 
low in both substrains. 
5-2-3 Ovarian sensitivity. 
It was demonstrated in the previous chapter that in rats 
treated with a high dose of TP the numbers of small antral 
follicles were lower than in oil-treated rats. Two ex-
periwents were performed to determine whether in addition 
to the absence of an ovulatory LH surge, the sensitivity of 
the ovaries of the androgen-treated rats to gonadotrophic 
stimuli might also be affected. 
In one experiment animals treated with oil, 5 or 1250 J.l9 TP 
were qiven 30 IU PMSG on dav 22. At that acre the incidence of 
ovulation caused by PMSG alone is almost zero, probably 
because insufficient LH is released. There is no difference 
between the three neonatal treatment ~roups in this respect. 
A sin~le s.c. injection of HCG was oiven 52 hrs after the 
PMSG administration in a dose ranoinq from 1 to 20 IU. 
Fiq. 5-2 shows that with additional HCG treatment all 
animals of the three treatment groups could be wade ovulatinq. 
All TP-treated rats showed a lack of response to doses of 
5 IU HCG and below. With hi~her doses of HCG the response 
of rats treated with 5 J.lg TP resembled that of controls, 
while the animals treated with 1250 J.lO TP were less respons-
ive. 
In a second experiment animals treated with 5 or 1250 J.lO 
TP were given a sinqle injection of 30 IU PMSG on day 28 
followed 52 hrs later by HCG in n stngle r9.ose of 2 to 20 IU. 
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Oil 4/8 6/9 8/9 8/8 8/8 
5 JJg TP 1/5 0/5 4/8 6/6 6/6 
1250JJg TP 3/5 1/5 3/7 7/7 7/8 
50 
40 
e 
-~ 30 
0 , 
> ~ 20 
> 0 
10 
0 
2 5 10 20 
HCG (I.U.; log sc:ale) 
Fig. 5-2 Effects on 30 IU pregnant mare serum gonadotrophin given on day 22, 
followed by different doses of human chorionic gonadotrophin (HCG) 52 h 
later, on the ovaries of rats treated on day 5 with oil (e-e) or with 5 )lg 
(A-.&.) or 1250 pg (0-0) testosterone propionate (TP). Vertical lines 
indicate.:!:_ S.E. M. Tabulated data =-no. of ovulating rats/total no. of 
rats. 
A group of animals which had undergone no treatment previously 
was given PMSG on day 28, hypophysectomized on day 29 and 
given HCG on day 30. 
When 30 IU PMSG was given on day 28 numerous ovulations 
occurred in all oil-treated animals but in none of the neo-
natally TP-treated ones (Table 5-2·). With the addition of 
10 IU HCG (Fig. 5-3) a normal quota of eggs was now also 
shed in rats treated with 5 ~g TP, but not in those treated 
with 1250 ~g TP. Further doubling of the dose of HCG also 
normalized the response of the latter group of animals. 
Hypophysectomized animals showed the same response as the 
rats treated with 5 ~g TP. 
It is concluded that the ovaries of the TP-treated rats 
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Oil 
Hypex 
5 JJg TP 
1250 JJg TP 
50 
40 
~ 
.r 3o 
' "3 > 
~20 
0 
> 0 
10 
0 
18/18 
6/15 17/18 
8/15 16/17 
f 
2 
16/16 
15/15 
14/15 
5 
15/15 
15/15 
15/15 
10 
HCG (I. U.; log scale) 
15/15 
15/15 
15/15 
20 
Fig. 5-3 Effects of 30 IU pregnant mare serum gonadotrophin (PMSG) given on 
day 28, followed by different doses of human chorionic gonadotrophin 
(HCG) 52 h later, on the ovaries of rats treated on day 5 with 5 p.g (A-A) 
or 1250 }lg (0-0) testosterone propionate (TP). Control animals were 
hypophysectomized (hypex) 1 day after PMSG injection (.c.-.c.). On the 
left : oil (8) and neonatally TP-treated groups without HCG treatment. 
vertical lines indicate:!:. S. E. M. Tabulated data =no. of ovulating 
rats/total no. of rats. 
are responsive to the combined gonadotrophic stimulation of 
PMSG and HCG. The ovarian sensitivity of the rats treated 
with 5 vq TP grossly resembled that of the oil-injected 
controls. However, the ovaries of rats treated with 1250 vg 
TP were less responsive. 
5-2-4 Response to different doses of PMSG. 
An experiment was carried out to test whether in TP-treated 
rats there occurred a shift in response to different doses 
of PMSG. 
Animals• of the three neonatal treatment groups were qiven 
a single dose of PMSG (varying between different animals 
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Oil 
5 JJg TP 
1250pg TP 
7/7 
6/8 
l/6 
3.7 
4/4 
4/6 
l/6 
7.5 
5/5 
5/10 
0/6 
15 
5/5 
5/6 
1/6 
30 
PMSG (I.U.; log scole) 
5/7 4/6 
5/7 4/10 
3/6 2/5 
60 90 
Fig. 5-4 Effects of different doses of pregnant mare serum gonadotrophin (PMSG) 
given on day 28, followed by 0. 5 mg progesterone 52 h later, on the ovaries 
of rats treated on day 5 with oil (e- e) or with 5 )lg (A- A ) or 1250 pg (0-0) 
testosterone propionate (TP). Vertical lines indicate .:!::. S. E. M. Tabulated 
data =no. of ovulating rats/total no. of rats. 
from 3.7 to 90 IU) on day 28 and 0.5 mg progesterone 52 hrs 
later. 
The results are given in Fig. 5-4. With doses of PMSG of 
3.7 to 30 IU all control animals shed eqgs. The averaqe 
number of ova varied with a maximum (of 47.8 per animal) 
after a dose of 15 IU. Very few of the animals treated with 
1250 ~g TP ovulated and the average number of ova per 
ovulating rat remained very low. The most effective dose was 
60 IU PMSG ( 50% ovulation, 4 ova/ovulating rat). The rats 
treated with 5 ~g TP occupied an intermediate position 
between the previous two groups, but resewbled the controls 
much more than the 1250 ~g TP-treated animals. At nearly all 
dose levels of PMSG, ovulation occurred in the majority of 
animals and the average nu~bers of ova shed showed a pattern 
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similar to that of controls. 
5-2-5 Effect of age on response to PMSG. 
A possible shift with age in the responsiveness to PMSG 
was also tested in the TP-treated rats. 
Animals of the three treatment groups were given 30 IU 
PMSG on one of the following days: day 22 (body weight range 
30-45 q), day 24 (35-50 q), day 26 (40-55 g), day 28 (50-65 g) 
or day 30 (60-75 g). All animals received progesterone (0.5 
mg) 52 hrs after the injection of PMSG. 
The results are given in Fig. 5-S. Nearly all control 
animals ovulated at every age tested. However, as tests were 
carried out at later ages more ova were shed. In rats treated 
with 1250 ~g TP the average numbers of ova remained uniformly 
Oil 8/Jl 18/18 16/18 16/16 10/10 
5 J.Jg TP 5112 11/17 10/14 16/17 9/12 
1250 IJ9 TP 4/9 7/14 7/15 2/10 1/8 
50 
40 
~ 
.r 30 
0 
-, 
> 
~ 20 
0 
> 
0 
10 
0 
22 24 26 28 30 
Age ct PMSG injection (days) 
Fig. 5-5 Effect of age on the induction of ovulation by 30 IU pregnant mare serum 
gonadotrophin (PMSG), followed by 0. 5 mg progesterone 52 h later, in rats 
treated on day 5 with oil (8-•) or with 5 pg (A-A) or 1250 pg (0-0) testos-
terone propionate (TP). Vertical lines indicate 2: S. E. M. Tabulated data = 
no. of ovulating rats/total no. of rats. 
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very low at every age tested. The rats treated with 5 ~g 
TP resembled the controls. The average numbers of ova rose 
gradually with increasing age in these animals. 
It is concluded from the experiments in 5-2-4 and 5-2-5 
that 5 ~g TP-treated rats did not differ from control rats 
with respect to the dose of PMSG administered, at which 
maximal ovulatory responses could be obtained and to the 
age of administration, at which maximal effect was observed. 
5-3 Discussion. 
An ovulatory surge of LH in neonatally untreated rats 
following PMSG administration has been reported previously 
(Ying and Meyer, 1972; Sorrentino et al, 1972; Endersby et 
al , 1973). The present experiments confirm these findings 
and show that ovulation induced by a single dose of PMSG 
follows the release of LH on the afternoon of the second 
day after PMSG administration. The release of LH was not 
accompanied by a significant decrease in pituitary LH 
content between the second and third day after PMSG admi-
nistration. This finding contrasts with the observations 
of other investigators, who found a fall in pituitary LH 
content either between 14.00 and 18.00 hrs on the second 
day after PMSG administration (Klausing and Meyer, 1968; 
Zarrow and Dinius, 1971} or between the second and third 
day after PMSG administration (Rennels and o•steen, 1967; 
McCormack and Meyer, 1968; Ying and Meyer, 1972}. There 
are at least two possible explanations for this discrepancy. 
The absence of a demonstrable fall in LH content in the 
experiment may be due to high individual variation. Another 
possibility is that the amount of LH released was too small 
in comparison with the amount present in the pituitaries, 
since in the R-Amsterdam substrain the LH surge two days 
after PMSG administration was rather low. A four-fold 
higher serum LH concentration at 15.00 hrs on day 32 was 
observed in F 1 hybrids of this substrain (R x U} after the 
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same PMSG treatment. This high LH concentration correlates 
well with a higher ovulation response in these F 1 hybrid 
animals. The large difference in the number of ova released, 
between the R-Amsterdam substrain and the "Endo" substrain 
indicates that great strain differences exist in the response 
to PMSG. 
Observations in TP-treated rats warrant the followina 
considerations. In the previous chapter it was demonstrated 
that female rats treated neonatally with a high dose of TP 
(1250 ~g) will be anovulatory from the time of vaginal 
opening. In these animals a single dose of PMSG at the age 
of 30 days failed to induce ovulation. This corresponds with 
earlier findings that ovulation or corpus luteum formation 
in prepuberal rats receiving 1250 ~q TP did not occur follow-
ing a single injection of PMSG (Schuetz and Meyer, 1963; 
Brown-Grant ~ al, 1964) or OB (DOrner and oOcke, 1964). The 
absence of an LH surge on day 32 in the present experiments 
indicates that such animals do not ovulate for lack of an 
LH stimulus. 
Female rats treated neonatally with 5 ~q TP, showinq 
ovarian cycles for some time after puberty, responded to 
PMSG with ovulation in a limited number of cases and with a 
very low number of ova. Also in these rats, no rise in serum 
LH could be found two days after PMSG administration. It is 
remarkable that although a third of the 5 ~g TP-treated rats 
ovulated, the serum LH concentrations of these animals on day 
32 were not different from those of non-ovulating 5 or 1250 
~g TP-treated rats. It may be argued that the LH peak present 
in the 5 ~g TP-treated rats, that did ovulate, occurred at 
a time different from that of oil-treated rats. Although 
this possibility cannot be excluded, it seems more likely 
that the LH assay lacks the sensitivity required to detect 
the minimal increase in serum LH which is sufficient to 
release a small number of ova. 
The presence in low dose TP-treated rats of postpuberal 
ovulatory cycles and the subnormal ovulatory response to 
PMSG administered prepuberally indicate that while after 
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puberty these animals seem to be normal, before puberty the 
mechanism inducing ovulatory surges of LH is already 
diminished. In the light of these finding one could expect 
differences in the magnitude of the spontaneous ovulatory 
LH surge between cyclic 5 ll,g TP-treated rats and normal rats. 
To date no such differences have been described. 
The finding of a lower pituitary LH content in 1250 ~g 
TP-treated rats agrees well with previous observations 
(Matsuyama et al, 1966i Barraclough, 1966b). The absence of 
an ovulatory LH surge in these rats is probably not due to 
the low pituitary LH content, since both types of TP-treated 
rats showed an absence of an ovulatory LH surge, while a low 
pituitary LH content could be demonstrated only in rats 
treated with the hiqh dose of TP. 
It is of interest that an injection of proqesterone two 
days after PMSG treatment increased the ovulation response 
in the 5 ~g TP-treated rats. Others have reported that 
progesterone will not induce ovulation in adult TP-treated 
rats (Barraclough et al, 1964), although the ovulatory 
response to electrical stlmulation of the brain increased 
if progesterone had previously been given (Barraclough and 
Gorski, 1961). The present data indicate that prepuberal 
5 119 TP-treated rats are still sensitive to the facilitati'ng 
action of progesterone. 
The ovaries of both groups of TP-treated rats were re-
sponsive to the combined PMSG and HCG treatment. A clearly 
decreased sensitivity of the ovaries was found in rats 
treated with the high dose of TP. On day 22 as well as on 
day 28, the response to PMSG followed by HCG was lower in 
the high dose TP-treated rats than that of oil-treated or 
hypophysectomized rats. In this respect it is of interest 
that a lower number of small follicles was seen on days 20 
and 30 in 1250 ).Jg TP-treated rats than in control rats (see 
chapter 4). The decreased sensitivity of the ovaries of 
these animals may be due to a relative lack of small 
follicles. 
The concept of an acceleration of sexual maturation in 
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TP-treated rats as proposed by van der Werff ten Bosch et 
al (1971) was tested in the PMSG experiments. The earlier 
presence of large follicles on day 35 in the 1250 ~g TP-
treated rats as compared with normal rats suggests that 
follicular growth is accelerated (see chapter 4). On the 
base of this concept it seemed possible, therefore, that 
PMSG-induced ovulation might occur at earlier ages in high 
dose TP-treated rats than in normal rats. This explanation 
is not supported by the data obtained. The ovulation response 
to PMSG in the high dose TP-treated rats was very low at all 
ages and with all doses of PMSG. The maximal response in 
control animals and 5 ~~ TP-treated animals occurred at the 
same dose level of 15 IU P~SG and at the same aqe. 
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Chapter 6 
Induction of ovulation by electrochemical stimulation of the 
brain in androgen-sterilized rats 
6-1 Introduction. 
In the previous chapter it was pointed out that even before 
puberty the ovulatory LH release mechanism is affected by 
administration of a high as well as by a low dose of TP neo-
natally. All the same, low dose TP-treated rats show ovulatory 
cycles after puberty. The question arose whether after attain-
ment of the anovulatory state, a difference in the potential 
of the brain to induce an ovulatory release of LH would 
persist between high and low dose TP-treated rats. Barraclough 
and Gorski found a difference between high and low dose TP-
sterilized rats with regard to the ovulatory response after 
electricai stimulation of the brain (Barraclough, 1966a). 
Electrical stimulation (ES) of the anterior hypothalamic-
preoptic area (AH-POA) was found to be ineffective in inducing 
ovulation in rats sterilized by 1250 ~g TP (Barraclough and 
Gorski, 1961) but effective in 75% of the rats sterilized by 
10 J.!g TP, although an injection of progesterone pri-or to 
ES was necessary (Gorski and Barraclough, 1963). ES of the 
arcuate-ventromedial nuclear complex (ARC-VMN) also revealed 
a difference between high and low dose TP-treated rats. While 
ES of the ARC-VMN failed to induce ovulation in 1250 ~g TP-
treated rats (Barraclough and Gorski, 1961) such a stimulation 
was effective in 10 ~g TP-treated rats (Gorski and 
Barraclough,1963). However, after pre-treatment with 
progesterone the difference disappeared. Both types of TP-
treated rats were now equally responsive toES of the ARC-VMN. 
In normal nembutal blocked prooestrous rats ES of the AH-POA 
as well as of the ARC-VMN resulted in complete ovulation 
Critchlow, 1958; Everett, 1961), Therefore, Barraclough and 
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Gorski concluded that neonatal TP treatment exerts its effect 
on the AH-POA resulting in the absence of the cyclic LH 
release and that in high dose TP-treated rats the area of the 
brain involved in the regulation of the tonic gonadotrophin 
release (ARC-VMN) was also affected. In contrast toES, 
electrochemical stimulation (ECS) of the AH-POA and of the 
ARC-VMN were equally efiective in normal and androgen-
sterilized rats (Terasawa et al, 1969; Everett et al, 1970; 
Kawakami and Terasawa, 1972). These results suggest that 
either no difference in exitability exist between cyclic and 
anovulatory animals at the level of the AH-POA and ARC-VMN 
or that this method is inadequate to detect such a difference 
between cyclic and anovulatory animals. 
Since Barraclough and Gorski have drawn for reaching 
conclusions from their experiments with ES, the present 
experiments were carried out to examine if after ECS of the 
two different brain areas high and low dose TP-sterilized 
rats would react with a different ovulatory response. 
6-2 Materials and methods. 
Female rats of the Wistar substrain, R-Amsterdam, were 
injected on day 5 with either 5 ~g or 1250 ~g TP. For reasons 
mentioned in the discussion no oil-treated rats were used. 
At the age of 5 to 6 months vaginal smears were taken daily 
for at least 10 days. Only animals which showed a cornified 
smear during the entire period were used. 
In one experiment HCG or LH-RH was used to induce ovulation. 
Both preparations were injected intravenously between 12.00 
and 14.00 hrs on the day before autopsy. 
ECS was performed under ether anaesthesia. The head of the 
animal was fixed with ear bars in a Kopf-stereotaxic apparatus. 
The upper incisor bar was adjusted 5.0 rnrn above the level of 
the interaural line. The electrode was placed in various parts 
of the brain using the coordinates of the atlas of de Groot 
(1959). For AH-POA stimulation the electrode was placed 0.5 
mm lateral to the midline, 7.5 rnrn anterior and 3.5 mm 
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Fig. 6-l Sagittal section of the rat brain, 0. 2 mm lateral of the midline, 
indicating the areas of stimulation. Abbreviations used in the figure: 
CC =corpus callosum, FOR o::ofornix, CA =commissura anterior, 
THAL ""thalamus, CO =chiasma opticum, POA =preoptic area, AHA"" 
anterior hypothalamic area, VMN =ventromedial nucleus, ARC= 
arcuate nucleus, EM =eminentia mediana, PIT =pituitary. Redrawn 
from de Groot's atlas. 
superior to the interaural line. For ARC-VMN stimulation the 
coordinates were: 0.25 rnrn lateral to the midline, 6.5 rnrn 
anterior to the interaural line and 0.5 rnrn abov€ the base of 
the skull (Fig. 6-1). The electrode was a unipolar stainless 
steel rod with a non-insulated tip of approximately 0.2 mm 
in diameter and 0.25 to 0.3 rnrn long. The ECS was performed 
unilaterally by passing a DC current in periods of 25 sec 
on and 25 sec off. Stimulus intensity and duration are given 
in Table 6-3. 
The animals were killed the following morning and ova in 
the fallopian tubes were counted. 
The statistical analyses of results were performed using 
2 the x -test or the Fischer test. 
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6-3 Experiments and results. 
6-3-l Induction of ovulation by HCG or LH-RH. 
Since the effectiveness of ECS of the hypothalamic areas 
is judged by the ovulatory response of the animals two 
conditions have to be fulfilled: 
1. The ovarian sensitivity to an ovulatory stimulus has to 
be comparable in both types of rats. 
2. The pituitaries of the two groups have to be equally 
responsive to LH-RH. 
Both ovarian and pituitary sensitivity are of importance since 
in the previous chapter it was demonstrated that at least at 
the age of 30 days the ovaries of the 1250 ~g TP-treated rats 
are less responsive to the combined action of PMSG and HCG, 
whereas the pituitaries of 1250 ~g TP-treated rats contained 
less LH so that these could be less responsive to LH-RH. 
To test the ovaries and the pituitaries varying doses of 
HCG and of LH-RH were injected intravenously in high and low 
dose TP-treated rats. The doses of LH-RH were calculated on 
the base of 100 g body weight. 
The results show no significant differences between the 
two treatment groups in the percentages of ovulating rats 
after treatment with either HCG (Table 6-1) or LH-RH (Table 6-2) 
Table 6-1 Induction of ovulation by HCG in rats made persistently oestrous by neonatal 
administration of 5 o1· 1250 pg testosterone propionate. 
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5.._,gTPondoy5 
ova per 
dose of rats that ovulated ovulating 
HCG {IU) number % rot (mean) 
0/4 0 
2 2/8 40 5.5 
4 8/8 100 9.3 
4/4 100 8~ 
1250 ).Jg TP on day 5 
ova per 
rats that ovulated ovulating 
number "lo rat (mean) 
0/4 0 
0/8 0 
8/10 80 9.6 
4/4 100 8.5 
significance* 
Fisher-Test 
n.s. 
n.s. 
n.s. 
n.s. 
• significance between percentage of ovulations in the two groups of rat {n.s.: not significant P>0.05) 
Table 6-2 Induction of ovulation by synthetic LH-RH in rats made persistently oestrous 
by neonatal administration of 5 or 1250 p.g testosterone propionate, 
I 
LH-RH 
(og/100 lii.w.) ·~~ 
200 
500 
do<e of r 
5 J.lg TP on day 5 
rots that ovuloted 
number % 
0/4 0 
0/4 0 
1/6 17 
3/6 50 
5/5 100 
ova per 
ovulating 
rat (mean) 
4 
12 
1250 J.~g TP on day 5 
rats that ovulated 
number % 
0/4 0 
0/5 0 
1/6 17 
4/7 57 
6/6 100 
ovo per 
ovulating 
rat (meon) 
3 
8 
6.5 
significance* 
fisher-Test 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
*significance between percentoges of ovulotions in the two groups of rots (n.s.: not significant P>0.05) 
It is concluded that the ovaries and pituitaries of 5 and 
1250 vg TP-treated rats were equally responsive to the ovu-
lation inducing influence of HCG and of LH-RH. 
6-3-2 Electrochemical stimulation of the AH-POA. 
ECS of the AH-POA was performed in high and low dose TP-
treated rats. The results are given in Table 6-3. 
Table 6-3 Effect of neonatal androgen-treatment on the induction of ovulation by 
electrochemical stimulation of the anterior hypothalamic-proptic area 
(AH-POA) and arcuate-ventromedial nulear complex (ARC-VMN). 
5)JgTPondoy5 1250 )Jg TP on doy 5 
total charge ovo per ovo per 
site of sec x pomp. rots thor ovulated ovulating rots that ovulated ovulating significance* 
stimulation (millicoulomb) number % rot (mean) number % rat (meon) x2-Test 
AH-POA 75. 30 (2.2) 11/19 58 9.6 1/8 12.5 12 
75. 60 (4.5) 19/22 86 10.3 6/12 50 13.3 
75 X J2Q (9 ) 8/9 89 12.5 11/14 78 11.8 n.s. 
150 X 120 (18) 8/8 100 12.5 9/9 100 9.8 n.s. 
ARC-VMN 75. 80 (6 I 2/12 17 14.5 4/17 24 12 n.s. 
75 X 160 (12) 
' 
8/10 so 9.4 8/8 100 10.4 n.s. 
*significance between percentages of ovulations in the two groups of rots (s: significant, P='O.OS) 
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A total charge of 2.2 milicoulomb (me) induced ovulation 
in 12.5% of the 1250 ~g TP-treated rats and in a signifi-
cantly higher percentage (58%) of the 5 ~g TP-treated group. 
The percentage of ovulating rats increased in both treatment 
groups after doubling the total charge. A significant 
difference in the percentage of ovulating rats between the 
1250 ~g TP-treated group (SO%) and the 5 ~g TP-treated group 
(86%) persisted. After a further increase of the total charge 
no difference was observed between the treatment groups. 
Finally after a stimulus of 18 me a 100% response was ob-
tained. The mean number of tubal ova per ovulating rat 
varied between 9.6 and 13.3 and showed no difference between 
the two treatment groups. These numbers of ova are similar 
to those found at oestrous in normal rats of this strain. 
6-3-3 Electrochemical stimulation of the ARC-VMN. 
ECS of the ARC-VMN was performed in high and low dose TP-
treated rats. Table 6-3 shows that a total charge of 6 me 
induced ovulation in about 20% of the animals both in the 
5 ~g TP group (2 out of 12) and in the 1250 ~g TP group (4 
out of 17). Doubling of the total charge increased the 
response in both treatment groups. However, also after this 
charge there was no significant difference between the 
responses in the two treatment groups. The number of ova 
shed was similar in both groups and similar to that found 
after stimulation in the AH-POA. 
6-4 Discussion. 
The present experiments demonstrate that ECS of the AH-POA 
is less effective in inducing ovulation in 1250 ~g TP-treated 
rats than in 5 ~g TP-treated rats. Barraclough and Gorski 
(1961) and Gorski and Barraclough (1963) studying the effect 
of ES of the AH-POA in 1250 and 10 ~g TP-treated rats, ob-
served that both treatment groups appeared refractory to ES. 
After an injection of progesterone prior toES, a modest 
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ovulatory response was found only in the 10 f.lg TP-·treated 
rats. The basic finding of Barraclough and Gorski, i.e., 
that ES of the AH-POA is less effective in 1250 ~g TP-treated 
rats than in 10 f.lg TP-treated rats, is in agreement with our 
results after ECS and indicates that after attainment of the 
anovulatory state low dose TP-treated rats are still different 
from high dose TP-treated rats. However, the difference 
between high and low dose TP-treated rats is larger after ES 
than after ECS. The larger ovulatory response in our experi-
ments than in those of Barraclough and Gorski, is in line 
with the findings of Everett and Radford (1961) and Terasawa 
and Sawyer (1969) that ECS is much more effective in inducing 
ovulation than ES. Terasawa et al (1969) comparing both ES 
and ECS of the AH-POA in normal and 50 flg TP-treated rats 
observed in androgenized rats a lower response to ES but no 
difference in the response to ECS. Their findings in TP-
treated rats differ from our results in that a much lower 
total charge was effective in all animals. Everett ~ al 
(1970) observed a POA threshold in rats treated with 1250 
flg TP which was close to that of cyclic rats. In another 
strain of rats (the C.D. strain) a larger difference between 
normal and TP-treated rats was found. Since TP-treated rats 
of this strain secreted large amounts of prolactin, it was 
suggested that the observed elevation of the POA threshold 
was due to an action of that hormone on the brain (Everett 
et al, 1970). 
A difference in the response to stimulation of the ARC-VMN 
between both types of rats as reported by Barraclough and 
Gorski after ES was not observed in the present experiments 
after ECS. 
From the present data and those of Barraclough (1966a) it 
cannot be concluded that the absence of an ovulatory LH surge 
in TP-treated rats is the result of a decreased excitability 
of neurous in the AH-POA, since no comparison has been made 
between cyclic and anovulatory animals. However, such a 
comparison would be difficult. In the first place because of 
the inequality of the hormonal evironment. It has been 
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demonstrated that ovarian steroids can influence the 
effectiveness of ECS (McDonald and Gilmore, 1971). Further-
more, the number of ovulating animals (Holsinger and Everett, 
1970} and the amount of LH released (Kalra and McCann, 1973) 
following ECS of the preoptic area varies during the 
oestrous cycle. 
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Chapter 7 
General discussion 
Summary of findings. 
Before discussing the results described in the chapters 3 
to 6, they will be summarized briefly. 
Chapter 3. Female rats treated with 1250 vg TP on day 5 
failed to ovulate from the time of vaginal opening. In 
contrast, animals treated with 5 vg TP on day 5 often showed 
ovarian cyclicity for more than three months. The ovaries 
of anovulatory animals contained large follicles but no 
corpora lutea and vaginal smears were permanently cornified. 
Chapter 4. The influence of neonatal TP on various para-
meters, related to the onset of reproductive function, was 
studied during the prepuberal period. An immediate effect o_f 
the TP injected was a decrease in FSH concentration in the 
blood. In animals treated with 1250 ~g TP this effect lasted 
10 to 15 days, resulting in the absence of the high serum 
FSH concentrations around day 15. Compared to control rats, 
the 1250 vg TP-treated rats showed less ovarian weight gain 
till day 30 and smaller numbers of small antral follicles on 
days 20 and 30. It is possible that the retarded follicular 
growth was due to the absence of a FSH peak around day 15. 
On day 35 the numbers of follicles in the largest volume class 
were higher in the 1250 vg TP-treated rats than in 5 vg TP- or 
oil-treated rats. Also, uterine weights were higher and 
vaginal opening, although of an abnormal character, occurred 
at an earlier age. These findings suggest that follicular 
growth was accelerated at that age in rats treated neonatally 
with a high dose of TP. 
In rats treated with 5 vg TP only a small decrease in serum 
FSH concentration was noticed. The treatment had no signific-
ant effect on ovarian or uterine weights, follicular develop-
ment or the time of vaginal opening. In all these animals 
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regular 5-day cycles were found after vaginal opening and 
the number of ova shed at oestrus was not different from 
that of control rats. 
Chapter 5. In this chapter the ovulatory response to an 
injection of PMSG in prepuberal TP-treated animals was 
studied. After an injection of 30 IU PMSG on day 30 all oil-
treated animals showed an increase in serum LH on the after-
noon of day 32 and fresh tubal ova on day 33. No such increase 
in serum LH concentrations was found on day 32 in 5 and 1250 
~g TP-treated rats. This probably explains that no ovulation 
occurred in the 1250 ~g TP-treated rats. However, a number 
of 5 ~g TP-treated rats ovulated. The absence of increased 
serum LH concentrations in these rats might be explained by 
the insensitivity of the LH assay system. Pituitary LH content 
was reduced in the high dose TP-treated rats. It was found 
that in the 5 ~g TP-treated rats an injection of progesterone 
52 hrs after PMSG administration increased the ovulatory 
response. With this combined PMSG and progesterone treat-
ment a dose- and an age-response curve was constructed for 
the three treatment groups. At every age and dose tested 
1250 ~g TP-treated rats either did not ovulate or responded 
with only a very small number of ova. The response of the 
5 ~g TP-treated rats was intermediate between control and 
high dose TP-treated rats, but the pattern of the dose- and 
age-response curves resembled that of control rats. A clearly 
decreased sensitivity of the ovaries was found only for the 
high dose TP-treated animals. 
Chapter 6. After attainment of the anovulatory state in 
adulthood, the ovulatory response to ECS of the brain was 
studied. A preliminary experiment showed that the pituitaries 
and the ovaries of high and low dose TP-treated rats were 
equally responsive to the ovulation inducing influence of 
LH-RH and HCG respectively. Aniwals made anovulatory with 
1250 ~g TP appeared less responsive to ECS of the AH-POA 
than animals made anovulatory with 5 ~g TP. However, ECS of 
the ARC-VMN was equally effective in 5 and 1250 ~g TP-treated 
rats. 
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Conclusions and a concept of the change with age of the 
"potential" of the brain to induce an LH surge in normal 
and androgenized rats. 
The observation of the delayed onset of the anovulatory 
state after a low dose of TP during the "critical period" 
confirms earlier findings (van der Werff ten Bosch, 1964a'b; 
Gorski, 1968). From the data of these authors it was 
concluded that the degree of alteration of the cyclic LH 
release mechanism depended on the dosage of androgen admi-
nistered. However, differences in ovarian cyclicity between 
5 ~g TP-treated rats and normal rats before these former 
animals have becorr:e anovulatory have not been described, and 
the observed difference with 1250 ~g TP-treated rats consist-
ed mainly in the time of the onset of the anovulatory state. 
The results of the present studies show that 
1. Even before puberty the mechanism which induces an 
ovulatory surge of LH is deficient in 5 ~g TP-treated 
rats and that such a mechanism is never operative at all 
in 1250 ~g TP-treated rats. 
2. After attainment of the anovulatory state, 5 ~g TP-
treated rats are still different from 1250 ~g TP-treated 
rats in that the former group is more responsive to ECS 
of the AH-POA. This last finding is in agreement with 
that obtained by Barraclough and Gorski with ES 
(Barraclough, l966a). 
The diagram in Fig. 7-1 depicts the development of the 
"potential" of the brain to induce an LH surge and the effect 
of neonatal TP on this "potential". This overview is based 
on the following considerations. 
(l) Normal female rats, which have passed the critical period 
unaffected by androgenic hormones, show an increase of this 
"potential" before puberty. Arguments, which support this 
view are the following. 
From day 20 onwards the brain is able to induce an ovulatory 
LH surge after appropriate hormonal stimulation, i.e., after 
PMSG (Zarrow and Quinn, 1963; McCormack and Meyer, 1964) 1 
aftP.r OB (Ying anO r,rP.P.Pr l97lb) and after progesterone in 
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ta ir>duce on LH surge 
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ovulation --------~=~~---------
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ECSexp. 
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5 J.J9 TP-treoted ret. 
becoming on<>vulotory 
12-18 months 
normal rats 
becoming onovulatory 
Fig. 7-1 Diagram illustrating the change with age of the tr potential" of the brain 
to induce an LH surge and the effect of testosterone propionate admini-
stered neonatally of this "potential". In the area below the dotted line the 
1
' potential'' of the brain is too low to induce an LH surge. In this area 
ovulation can only be induced by electrical or electrochemical stimulation 
of the brain. 
ovariectomized OB-primed rats (Caligaris ~ al, 1972). These 
authors all showed that the response to the various stimulat-
ing agents increases with age and reaches a maximum at around 
day 28. Although the increase with age of the ovulatory 
response to PMSG and OB may be due to an increased follicular 
growth, the gradually increasing LH surges evoked by pro-
gesterone in the ovariectomized OB-primed rats (Caligaris 
et al, 1972) suggest an increase with age of the "potential" 
of the brain to induce an LH surge. 
(2) The ''potential'' decreases gradually till at the age of 
12 to 18 months it falls below the threshold which is 
required to induce spontaneous ovulations. Arguments 
supporting this view are the observations that female rats 
become anovulatory at old age (Wolfe et al, 1940; Ingraw, 
1959; Mandl, 1961). This anovulatory state seems to be due 
to the failure of the brain to induce an ovulatory release 
of LH, since transplantation of ovaries (Ascheiw, 1964/1965) 
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or pituitaries (Peng and Huang, 1972) from "senile 11 rats to 
cyclic females can be followed by resumption of regular 
oestrous cycles. 
The "potential" of the brain to induce an LH surge will be 
proportional to the amount of gonadotrophin released when 
the enteroceptive and exteroceptive sti~uli which evoke the 
LH surge do not vary. This would mean that in normal rats the 
magnitude of the LH peak becowes smaller as the animals grow 
older. Some findings favour this idea. In a study in which 
serum LH concentrations were measured during the day before 
first ovulation an LH peak was observed which seemed to be 
higher than that on the afternoon of prooestrus in adulthood 
(Meijs-Roelofs and Uilenbroek, unpublished observations). 
Furthermore, it has been demonstrated, with timed sodium 
pentobarbitone injections on the afternoon of prooestrus, 
that less than the normal peak level of LH successfully 
elicits ovulation (Greig and Weisz, 1973). A gradual decrease 
of the LH peak height with higher ages will therefore not 
irrmediately result in anovulation. An argument for the view 
that the cyclic period ends because the prooestrus LH peak 
fails to reach an ovulatory level can be deduced from the 
finding of atretic large follicles at the time of the 
expected onset of anovulation in ovarian grafts in neonatally 
castrated male rats (van der Schoot, 1973). Since it has been 
demonstrated that preovulatory follicles become atretic after 
subovulatory gonadotrophin stimulation (Verrneiden and 
Zeilmaker, in preparation), the presence of atretic follicles 
at the expected time of ovulation in neonatally castrated 
male rats may indicate that the peak level of LH was in-
sufficient for induction of ovulation. 
The available data support the idea that animals treated 
with 5 f.lg TP on day 5 have a lower "potential" of the brain 
to induce an LH surge than untreated rats at all ages (Fig. 
7-1). However, their pattern is not different from that of 
normal rats. The lower ovulatory response after P~SG in the 
prepuberal period and the early onset of the anovulatory 
state in the postpuberal period are indicati0ns that the 
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brain 11 potential 11 is subnormal. The parallel between the 
cessation of ovulatory cycles in 11 Senile" rats and in low 
dose TP-treated rats has been Urawn earlier by van der 
Werff ten Bosch et al (1971). They speculated that one effect 
of neonatal TP-treatment might be an acceleration of the 
ageing of the central nervous system mechanism which controls 
the gonadotrophin release responsible for ovulation. The 
present data indicate that neonatal TP-treatment causes an 
underdevelopment of this mechanism. 
In contrast to that of 5 ~g TP-treated rats, the brain of 
1250 ~g TP-treated rats never reaches the 11 potential" for 
spontaneous induction of an ovulatory surge of LH. Also in 
response to different hormones, an LH release fails to occur 
as was demonstrated after PMSG (this thesis) and after OB 
(DOrner and DOcke, 1964) in prepuberal TP-treated rats, and 
after OB in adult ovariectomized TP-treated rats (Taleisnik 
et al, 1971). The difference in responsiveness between 5 
and 1250 ~g TP-treated rats to ECS of the AH-POA indicates 
that the brain of 1250 ~g TP-treated rats has been more 
intensively affected by neonatal androgen treatment than 
the brain of 5 ~g TP-treated rats. 
Concepts to explain the sterilizing effect of early TP-
treatment. 
It is still unclear why the brains of androgenized rats 
are unable to induce cyclic release of LH. It is possible 
that neuronal connections indispensable for the induction 
of an ovulatory release of LH fail to develop. MorphologiCal 
differences correlated with the neonatal presence or absence 
of androgens have been described by Raisman and Field (1973) 
They observed a lower incidence of synapses on dendritic 
spines from other areas than from the stria terminalis in the 
preoptic area of normal males and of females treated with 
1250 ~g TP on day 4. Conversely a high incidence of synapses 
on dentritic spines was observed in norwal females and in 
males castrated within 12 hrs of birth. However, one can only 
speculate about the relationship between these synapses and 
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the rr.achanism which induce LH release. 
One of the most popular explanations of the inability of 
the brain to induce cyclic LH release states that the 
sensitivity of the brain to oestrogen is decreased (Flerk6, 
1971; Gorski, 1971). It has been suggested that exposure 
of the developing brain to androgen alters the formation of 
steroid receptor mechanism necessary for the induction of 
ovulation (Gorski, 1971). It has been shown that the uptake 
of 3H-oestradiol in the uterus, pituitary and the hypotha-
lamus of androgen-sterilized rats is decreased (Flerk6 et al, 
1969,1971; Anderson and Greenwald, 1969; McGuire and Lisk, 
1969; McEwen and Pfaff, 1970 and vertes and King, 1969). In 
rats treated with 1000 vg TP on day 2 vertes and King (1971) 
observed a decreased oestrogen binding in both nuclear and 
cytoplasmatic fractions from the anterior hypothalamus at 
day 60, but only in the nuclear fraction at day 28. 
A decreased sensitivity of the brain to the inhibitory 
feedback action of oestrogen has been reported by Petrusz 
and Nagy (1967) and by Barraclough and Haller (1970). Petrusz 
and Nagy observed that more oestrogen was required to suppress 
ovarian compensatory hypertrophy in androgenized rats than in 
normal rats. However, this experiment is not conclusive 
because the endpoint studied, the ovary, is dissiwilar in the 
two groups of animals; while corpora lutea were present in 
control animals, they were lacking in androgenized rats. 
This difficulty was avoided by Barraclough and Haller (1970) 
They estimated the effect of oestrogen on plasma LH levels 
in ovariectomized rats and observed that five times more OB 
was needed to suppress plasma LH concentrations in TP-
sterilized rats than in normal rats. However, the decrease 
in plasma LH concentrations of TP-treated rats after ovari-
ectomy in these experiments is in contrast to the observa-
tions of other investigators (Schiavi, 1969; Labhsetwar, 
1970; Uilenbroek, 1972). 
A single injection of oestradiol benzoate on day 5 also 
has a sterilizing effect (Gorski 1 1963) and neonatal admini-
stration of an antioestrogen (MER-25) inhibits the sterilizing 
77 
effect of TP (McDonald and Doughty, 1972a). In addition to 
the assumption that the neonatally administered testosterone 
acts directly on the developing brain as such, it is 
conceivable that the testosterone injected is converted to 
oestrogen and that this oestrogen then acts on the brain. 
It has been demonstrated that aromatization of androstene-
dione can occur in the foetal hypothalamus (Naftolin et al, 
1971). Furthermore, dihydrotestosterone which cannot be 
converted to oestrogen has no sterilizing effect when 
administered neonatally to 
1970; Arai, 1972; McDonald 
female rats (Luttge and Whalen, 
b 
and Doughty, 1972 I. 
An alternative hypothesis, which explains the sterilizing 
action of both testosterone and oestrogen, has been proposed 
by Sheridan et al (1973b). These investigators suggested 
that not the presence of high amounts of steroids in itself 
but that the absence of high concentrations of serum 
gonadotrophins during the neonatal period might induce 
sterilization. Indeed, the correlation between serum levels 
of FSH during the neonatal period and the type of gonado-
trophin regulation in adulthood is striking. High concentra-
tions of serum FSH neonatally - present in normal females 
(Weisz and Ferin, 1970; Meijs-Roelofs et al, 1973b) and in 
neonatally castrated males (Goldman et al, 1971) - correlate 
with cyclic release of gonadotrophins in adulthood. Low 
concentrations of serum FSH neonatally - present in normal 
males (Weisz and Ferin, 1970) and in TP-treated females 
(Weisz and Ferin, 1970; Goldman and Gorski, 1971 and this 
thesis) - correlate with the absence of cyclic variations 
in gonadotrophin secretion in adulthood. However, dihydro-
testosterone, which has a strong antigonadotrophic action 
both in adult rats (Beyer ~ al, 1972; Swerdloff et al, 
1972; Verjans ~ al, in preparation) and in prepuberal rats 
(Feder, 1971; Rosekrans and Aafjes, unpublished results) is 
unable to induce sterilization when given neonatally. If the 
hypothesis of Sheridan et al is correct any agent which sup-
presses gonadotrophin secretion would eliminate the capacity 
of ovarian cyclicity. It therefore seems likely that the 
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observed temporary decrease in serum FSH concentrations 
which follows neonatal TP-treatment is of no decisive 
importance for the development of the early-androgen 
syndrome. 
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Summary 
Female rats, treated with androgens during the early post-
natal period, may become anovulatory in adulthood. In this 
thesis the development of this so called "early-androgen 
syndrome" has been described for rats treated on day 5 with 
a high (1250 ~g) or with a low (5 ~g) dose of testosterone 
propionate (TP) . Various indices for hypothalarno-hyporhysial-
ovarian activity were monitored: (1) during the prepuberal 
period, (2) at the time at which puberty occurs in normal 
rats and (3) in adulthood. 
Following an injection of 1250 ~g TP on day 5 serum FSH 
concentrations did not reach the high levels normally seen 
in untreated rats between days 10-15 (Chapter 4) . From day 
20 onwards the FSH pattern was not different from that of 
normal rats. The number of small antral follicles was lower 
compared to normal rats on days 20 and 30. This may have 
been due to the subnormal FSH levels before day 20. The 
development of the mechanism to induce an ovulatory surge 
of LH was tested by attempting to induce ovulation with 
PMSG (Chapter 5). In 1250 ~g TP-treated rats an injection 
of PMSG was not followed by a surge of LH, and ovulation 
did not occur. It is concluded that the mechanism to induce 
an ovulatory surge of LH does not develop in rats with a 
high dose of TP. At the end of the prepuberal period the 
following abnormalities could be demonstrated: abnormal 
vaginal development, earlier presence of large follicles 
and a higher uterine weight (Chapter 4). The absence of 
spontaneous ovulations in adulthood described in Chapter 
3 is in agreement with the above reached conclusion that 
the mechanism to induce LH surqes does not develop in rats 
treated with a high dose of TP. 
Administration of the low dose of 5 ~g TP has an effect 
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on ovarian cyclicity that differs from the effect obtained 
with 1250 ~g TP. Animals treated with 5 ~g TP show ovarian 
cyclicity for some time after puberty before they become 
anovulatory (Chapter 3). Such a treatment on day 5 had no 
marked effect on serum FSH concentration and follicular 
development in the prepuberal period: the serum FSH con-
centrations were lower than in normal rats for only three 
days and the composition of the follicular population was 
not different from that of normal rats (Chapter 4) . The 
ovulatory response to PMSG administration, however, was 
subnormal and a pre-ovulatory LH surge could not be demon-
strated (Chapter 5). In contrast to the effect in 1250 ~g 
TP-treated rats, the facilitating action of progesterone on 
the ovulatory response to PMSG was present in the 5 ~g TP-
treated rats. It is concluded that neonatal administration 
of a low dose of TP partially inhibits the development of 
the mechanism to induce an ovulatory surge of LH. However, 
the diminished "potential" of the brain to induce an LH 
surge in the prepuberal period is of no consequence in the 
early period after puberty. The animals started cycling at 
the same age as normal animals and continued to cycle for 
some time. Thereafter cyclicity stopped presumably for lack 
of an LH stimulus (Chapter 3) . 
Although animals treated neonatally with either a low or 
a high dose of TP eventually became anovulatory, a difference 
in the "potential" of the brain to induce an_ ovulatory surge 
of LH persisted since 5 ~g TP-treated rats showed a lower 
threshold to electrochemical stimulation of the anterior 
hypothalamic-preoptic area (Chapter 6) . 
A concept to describe the change with age of the '1potential" 
of the brain to induce an LH surge is discussed in Chapter 7. 
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Samenvatting 
Vrouwelijke ratten, die kort na de geboorte behandeld zijn 
met androgenen, kunnen anovulatoir worden op volwassen leef-
tijd. In dit proefschrift wordt de ontwikkeling beschreven van 
dit zogenaarnde " vroege androgen-syndroom" en wel voor ratten 
die op de vijfde dag behandeld zijn met een hoge (1250 ~g) 
of met een lage (5 ~g) dosis testosteron propionaat (TP). 
Verschillende parameters voor hypothalamus-hypophyse-ovarium 
activiteit zijn bestudeerd: (1) in de prepuberale periode, 
(2) in de tijd dat puberteit optreedt bij norrnale ratten en 
{3) bij ratten op volwassen leeftijd. 
Na een injectie met 1250 ~g TP op dag 5 bereikten de serum 
FSH concentraties niet die hoge waarden die norrnaal in onbe-
handelde ratten worden waargenomen tussen dag 10 en 15 
(hoofdstuk 4) . Vanaf dag 20 evenwel was het FSH patroon niet 
verschillend van dat van normale ratten. Het aantal kleine 
fol1ikels met een antrum was op dag 20 en 30 kleiner dan in 
norrnale ratten. Dit kan het gevolg zijn van de lage FSH 
spiegels voor dag 20. De ontwikkeling van het mechanisme om 
ovulatoire LH pieken op te wekken werd getest door te pro-
beren ovulatie op te wekken met PMSG (hoofdstuk 5) . In de 
met 1250 ~g TP behandelde ratten werd een injectie met PMSG 
niet gevolgd door een LH piek en ovulatie vond niet plaats. 
Geconcludeerd wordt dat het mechanisme om ovulatoire LH 
pieken op te wekken zich niet ontwikkelt in ratten behandeld 
met een hoge dosis TP. Tegen het einde van de prepuberale 
periode konden de volgende abnorrnaliteiten worden aangetoond: 
een abnormale vagina ontwikkeling, eerder optreden van grate 
follikels en een hager uterus gewicht (hoofdstuk 4) . De af-
wezigheid van spontane ovulaties op volwassen leeftijd, zeals 
beschrev~n in hoofdstuk 3, kornt overeen met de bovengenoemde 
conclusie, dat het rnechanisrne om LH pieken c; ce wekken zich 
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niet ontwikkelt in ratten behandeld met een hoge dosis TP. 
Toediening van 5 ~g TP, de lage dosis, heeft op ovarium 
cycliciteit een effect dat verschilt van het effect dat ver-
kregen wordt in ratten behandeld met 1250 ~g TP. De met een 
lage dosis TP behandelde dieren vertonen na de puberteit ge-
durende enige tijd ovariele cycli voordat ze anovulatoir worden 
(hoofdstuk 3). Een dergelijke behandeling had geen uitge-
sproken invloed op de serum FSH concentraties en op de folli-
kel ontwikkeling in de prepuberale periode: de serum FSH 
concentraties waren slechts gedurende 3 dagen lager dan in 
normale ratten en de samenstelling van de follikel populatie 
was niet verschillend van die van norrnale ratten (hoofdstuk 
4). De ovulatie respons op PMSG toediening evenwel was lager 
dan in onbehandelde ratten en een preovulatoire LH piek kon 
niet worden aangetoond (hoofdstuk 5) . Progesteron had een 
faciliterende werking op de ovulatie respons in 5 ~g TP 
behandelde ratten na toediening van PMSG. Oat was niet het 
geval in 1250 ~g TP behandelde ratten. Geconcludeerd wordt 
dat neonatale toediening van een lage dosis TP de ontwikkeling 
van het mechanisme om ovulatoire LH pieken te induceren 
gedeeltelijk rernt. De verminderde "potentie" van de hersenen 
om LH pieken op te wekken in prepuberale ratten heeft geen 
invloed op de eerste periode na de puberteit. De dieren ver-
toonden ovariele cycli op dezelfde leeftijd als norrnale 
ratten. Na enige tijd hield de cycliciteit op, vermoedelijk 
door het ontbreken van een LH stimulus (hoofdstuk 3) . 
Ofschoon zowel de met hoge als de met lage dosis TP be-
handelde dieren tenslotte anovulatoir werden blee£ er een 
verschil bestaan in de "potentie 11 van de hersenen om een 
ovulatoire LH piek op te wekken: 5 ~g TP behandelde ratten 
vertoonden een lagere drempelwaarde voor electrochernische 
stirnulatie van het anterior hypothalarnisch-preoptische ge-
bied (hoofdstuk 6). 
In hoofdstuk 7 wordt een concept besproken dat weergeeft 
het verloop met de leeftijd van de "potentie'1 van de hersenen 
om ovulatoire LH pieken op te wekken. 
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